<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="review-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">jmir</journal-id><journal-id journal-id-type="index">1</journal-id><journal-title>Journal of Medical Internet Research</journal-title><abbrev-journal-title>J Med Internet Res</abbrev-journal-title><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v27i1e77853</article-id><article-id pub-id-type="doi">10.2196/77853</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Prevalence of Dropout and Influencing Factors in Digital Psychosocial Intervention Trials for Adult Illicit Substance Users: Systematic Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Li</surname><given-names>Jiayi</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Liu</surname><given-names>Xinyi</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Du</surname><given-names>Xiayu</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mi</surname><given-names>Tingni</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ren</surname><given-names>Zhihong</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><institution>School of Psychology, Central China Normal University</institution><addr-line>The 8th floor, Nanhu Complex Building, No.152 Luoyu Road</addr-line><addr-line>Wuhan</addr-line><country>China</country></aff><aff id="aff2"><institution>Key Laboratory of Adolescent CyberPsychology and Behavior (CCNU), Ministry of Education</institution><addr-line>Wuhan</addr-line><country>China</country></aff><aff id="aff3"><institution>Key Laboratory of Human Development and Mental Health of Hubei Province</institution><addr-line>Wuhan</addr-line><country>China</country></aff><aff id="aff4"><institution>School of Psychology, Liaoning Normal University</institution><addr-line>Dalian</addr-line><country>China</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Zhuang</surname><given-names>Yan</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Obianyo</surname><given-names>Chekwube</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Heidari</surname><given-names>Mohammad Eghbal</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Balogun</surname><given-names>Oluwadotun Catherine</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Long Guo</surname><given-names>Jong</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Zhihong Ren, PhD, School of Psychology, Central China Normal University, The 8th floor, Nanhu Complex Building, No.152 Luoyu Road, Wuhan, 430079, China; <email>ren@ccnu.edu.cn</email></corresp><fn fn-type="equal" id="equal-contrib1"><label>*</label><p>these authors contributed equally</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2025</year></pub-date><volume>27</volume><elocation-id>e77853</elocation-id><history><date date-type="received"><day>21</day><month>05</month><year>2025</year></date><date date-type="rev-recd"><day>12</day><month>09</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>09</month><year>2025</year></date></history><copyright-statement>&#x00A9; Jiayi Li, Xinyi Liu, Xiayu Du, Tingni Mi, Zhihong Ren. Originally published in the Journal of Medical Internet Research (<ext-link ext-link-type="uri" xlink:href="https://www.jmir.org">https://www.jmir.org</ext-link>), 10.10.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://www.jmir.org/">https://www.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://www.jmir.org/2025/1/e77853"/><abstract><sec><title>Background</title><p>Illicit drug use has become a significant global public health issue, and digital interventions offer new approaches to address this challenge. However, there is a gap in existing research on the dropout rate of adult illicit drug users receiving digital psychosocial interventions.</p></sec><sec><title>Objective</title><p>This study aims to evaluate the dropout rate of adult illicit drug use following digital psychosocial interventions during treatment and the longest follow-up, as well as its predictive factors.</p></sec><sec sec-type="methods"><title>Methods</title><p>Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, studies published up to August 27, 2025, were searched in the Web of Science, PubMed, PsycINFO, Embase, and Cochrane Controlled Trials Register. Randomized controlled trials of digital psychosocial interventions for adult illicit drug users that reported dropout rates were included. Two researchers independently screened studies, extracted data, and assessed bias risk using the Cochrane risk of bias tool (ROB 2.0). A random-effects model in Comprehensive Meta-Analysis software (CMA 4.0) was used for meta-analysis, along with heterogeneity testing, sensitivity analysis, and publication bias assessment. Finally, a moderating analysis was conducted based on the extracted data.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 41 studies involving 9693 participants and reporting 48 dropout rates were included. The mean dropout rate in the intervention group after 18 studies was 22% (95% CI 0.13&#x2010;0.36), which was lower than the control group&#x2019;s 26% (95% CI 0.16&#x2010;0.39). High heterogeneity was observed between studies (Q=396.18, <italic>df</italic>=17, <italic>P</italic>&#x003C;.001, I&#x00B2;=96%), and moderating analysis revealed that high heterogeneity in dropout rates was associated with four variables across three major characteristics: (1) participant demographic characteristics: employment rate; (2) participant clinical characteristics: baseline clinical diagnosis and baseline drug use type; and (3) intervention characteristics: intervention frequency. In the 30 studies with the longest follow-up period in the intervention group, the dropout rate was 28.2% (95% CI 0.19&#x2010;0.39), comparable to the control group&#x2019;s 27.8% (95% CI 0.20&#x2010;0.37). Extremely high variability was observed between studies (Q=1293.13, <italic>df</italic>=29, <italic>P</italic>&#x003C;.001, I&#x00B2;=98%), and moderating analysis showed that high heterogeneity in dropout rates was associated with 4 variables across three major characteristics: (1) participant demographic characteristics: single individuals; (2) participant clinical characteristics: baseline medication frequency; and (3) treatment characteristics: recruitment method and the degree of digitalization. Additionally, publication bias assessment and sensitivity analysis supported the robustness of the study results.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>This study explored the impact of digital psychosocial interventions on treatment adherence among adult illicit drug users, revealing complex factors affecting dropout rates through mediation analysis. These findings not only emphasize the necessity of further research but also provide important evidence for developing precision interventions, holding significant implications for both theory and clinical practice.</p></sec><sec><title>Trial Registration</title><p>PROSPERO CRD42024534389; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024534389</p></sec></abstract><kwd-group><kwd>digital psychosocial intervention</kwd><kwd>dropout rate</kwd><kwd>illicit drug use</kwd><kwd>meta-analysis</kwd><kwd>systematic review</kwd><kwd>influencing factor</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The global issue of illicit drug use has worsened, with 292 million users in 2022, a 20% increase over the past decade [<xref ref-type="bibr" rid="ref1">1</xref>]. Cannabis is the most widely used illicit drug (228 million), followed by opioids (60 million), cocaine (23 million), and others [<xref ref-type="bibr" rid="ref1">1</xref>]. Illicit drug users face various psychological and physiological problems, including mental disorders, cognitive deficits, cardiovascular dysfunction, and blood-borne infections. The social burden is also high, due to links with crime, violence, and sexual abuse [<xref ref-type="bibr" rid="ref2">2</xref>]. Treatment is urgently needed, but globally, only about 10% of users receive treatment, a decline since 2015 [<xref ref-type="bibr" rid="ref1">1</xref>].</p><p>Traditional face-to-face psychosocial treatments remain important for illicit drug users but often fail to meet the needs of most patients due to time, location, and social stigma [<xref ref-type="bibr" rid="ref3">3</xref>]. The COVID-19 pandemic accelerated the development of telehealth [<xref ref-type="bibr" rid="ref4">4</xref>] and pushed digital interventions from early simple interactions to more complex forms [<xref ref-type="bibr" rid="ref5">5</xref>]. Modern digital interventions can provide multiple interaction methods via smart devices, such as apps, websites, email, text messages, video, audio, and computer programs. They overcome the limitations of traditional treatments and are valued for their flexibility and cost-effectiveness [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref10">10</xref>], better meeting personalized needs and improving treatment engagement [<xref ref-type="bibr" rid="ref11">11</xref>]. Meta-analyses show that digital interventions are effective across different populations of illicit drug users [<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p><p>However, dropout rates are particularly prominent in digital interventions [<xref ref-type="bibr" rid="ref15">15</xref>-<xref ref-type="bibr" rid="ref17">17</xref>]. Meta-analyses indicate that about one-third of individuals with substance use disorders fail to complete treatment [<xref ref-type="bibr" rid="ref18">18</xref>] and only 48% of early dropouts seek help again [<xref ref-type="bibr" rid="ref19">19</xref>], significantly increasing the risk of adverse outcomes [<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref>]. Methodologically, the relatively high dropout rate limits the completeness of research findings, affecting the validity of results and the interpretation of treatment effects [<xref ref-type="bibr" rid="ref22">22</xref>]. To improve the accuracy, this study clearly distinguishes three key concepts: engagement refers to behavioral involvement during use [<xref ref-type="bibr" rid="ref23">23</xref>]; adherence reflects the alignment between actual behavior and intervention expectations [<xref ref-type="bibr" rid="ref24">24</xref>]; while the dropout rate in this study is strictly defined as participants leaving, being lost to follow-up, or stopping participation before the outcome assessment for any reason. This conceptual clarification both distinguishes commonly confused terms and provides a methodological basis for enhancing the effectiveness of digital interventions, with important clinical implications.</p><p>Although the dropout rate is an important outcome indicator of intervention efficacy [<xref ref-type="bibr" rid="ref25">25</xref>], few studies have examined dropout rates among illicit drug users in digital interventions. A meta-analysis published in 2017 was the first to evaluate internet-based interventions in reducing illicit substance use after treatment and follow-up, but dropout rate was not the focus [<xref ref-type="bibr" rid="ref12">12</xref>]. Moreover, existing research lacks systematic examination of clinical factors and intervention design, as well as dynamic assessment of dropout patterns at different time points [<xref ref-type="bibr" rid="ref26">26</xref>-<xref ref-type="bibr" rid="ref28">28</xref>], directly limiting the optimization of targeted intervention strategies.</p><p>Based on current research, this study aims to address the gap in dropout rate research in digital interventions. The study compared average dropout rates between the digital intervention and control groups to assess treatment retention under different experimental conditions. It also analyzed how variables at posttreatment and the longest follow-up time points affected dropout rates in the intervention group to support personalized intervention design for different research stages. These findings are important for advancing academic research and expanding clinical applications [<xref ref-type="bibr" rid="ref29">29</xref>].</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Protocol Registration</title><p>This study strictly adheres to the guidelines of the Cochrane Handbook for Interventions [<xref ref-type="bibr" rid="ref30">30</xref>] and is reported according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines [<xref ref-type="bibr" rid="ref31">31</xref>] (the complete PRISMA checklist is available in <xref ref-type="supplementary-material" rid="app3">Checklist 1</xref>). The research protocol has been registered in the PROSPERO system: CRD42024534389.</p></sec><sec id="s2-2"><title>Search Strategy</title><p>To comprehensively and systematically collect relevant literature, this study searched five major databases up to August 27, 2025, including Web of Science, PubMed, PsycINFO, Embase, and the Cochrane Controlled Trials Register. The search strategy combined controlled vocabulary (eg, MeSH terms) and free-text keywords using Boolean operators (&#x201C;AND&#x201D; and &#x201C;OR&#x201D;). The main search terms included the following: (&#x201C;digital intervention&#x201D; OR &#x201C;internet intervention&#x201D; OR &#x201C;e-health&#x201D; OR &#x201C;m-health&#x201D;) AND (&#x201C;drug abuse&#x201D; OR &#x201C;substance use disorder&#x201D; OR &#x201C;illicit drugs&#x201D;) AND (&#x201C;psychotherapy&#x201D; OR &#x201C;psychoeducation&#x201D; OR &#x201C;psychodynamic&#x201D;) AND (&#x201C;randomized controlled trial&#x201D; OR &#x201C;single blind procedure&#x201D; OR &#x201C;random sample&#x201D;). The complete search strategy for each database is provided in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p></sec><sec id="s2-3"><title>Inclusion and Exclusion Criteria</title><p>Inclusion criteria were as follows: (1) Individuals aged 18 years and above with illicit drug use behavior. Illicit drugs refer to controlled substances used for nonmedical or nonscientific purposes, including but not limited to cannabis, cocaine, amphetamines, and opioids [<xref ref-type="bibr" rid="ref1">1</xref>]. (2) Digital psychosocial intervention is the primary treatment. Operationally defined as structured psychological intervention primarily delivered through digital platforms, including mobile applications, web-based programs, or digital communication tools, with or without minimal human support. (3) The article must report sample size and dropout rates. (4) Randomized controlled trials. Exclusion criteria were as follows: (1) treatment involving only face-to-face therapy. (2) mixed samples with insufficient proportion of illicit drug users (less than 80%) or without independent subgroup data (eg, alcohol and tobacco users). (3) non-English studies. (4) unpublished reports, study protocols, meta-analyses, reviews, doctoral theses, or other gray literature.</p><p>To ensure the accuracy of literature screening, a dual-screening process was adopted. First, two researchers independently screened the titles and abstracts of retrieved literature to exclude those clearly not meeting inclusion criteria. Subsequently, the full texts of the literature were reviewed for further evaluation. Finally, manual searches were conducted on the reference lists of included studies and related reviews to identify additional studies meeting inclusion criteria. Any disagreements were resolved through discussion.</p></sec><sec id="s2-4"><title>Select Variables and Data Extraction</title><sec id="s2-4-1"><title>Outcome Variable</title><p>This study uses the dropout rate from randomized controlled trials as the primary outcome measure. Considering that the influencing factors at different treatment stages may vary [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref32">32</xref>-<xref ref-type="bibr" rid="ref34">34</xref>], the dropout rate data of the intervention and control groups at the end of treatment and at the longest follow-up time were extracted separately.</p></sec><sec id="s2-4-2"><title>Moderator Variables</title><p>Previous studies have explored the factors influencing dropout among illegal drug users [<xref ref-type="bibr" rid="ref35">35</xref>], but due to differences in confounding variable control methods and insufficient understanding of the complexity of predictive factors, the results have been inconsistent [<xref ref-type="bibr" rid="ref32">32</xref>]. Withdrawal from treatment is a dynamic process, and its mechanisms involve complex interactions of multiple factors [<xref ref-type="bibr" rid="ref36">36</xref>]. It is difficult to fully explain the complexity of single-variable analysis [<xref ref-type="bibr" rid="ref22">22</xref>]. Therefore, this study refers to previous research [<xref ref-type="bibr" rid="ref37">37</xref>] and selects multidimensional variables (<xref ref-type="table" rid="table1">Table 1</xref>): (1) Demographic characteristics of participants: most studies emphasize the role of patient-related variables in predicting dropout [<xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref>], and investigating individual differences (such as age, gender, race, digital literacy, etc.) is crucial for developing treatment interventions for specific populations [16]. (2) Baseline clinical characteristics of participants, including the type of illegal drug use, medication patterns, frequency of use, duration of use, and comorbid conditions. Different drugs may have differentiated effects on dropout rates due to their unique pharmacological mechanisms and withdrawal characteristics [<xref ref-type="bibr" rid="ref40">40</xref>]. Additionally, the presence of comorbid mental disorders may exacerbate the likelihood of treatment interruption [<xref ref-type="bibr" rid="ref41">41</xref>], which also needs to be considered. (3) Therapist characteristics: the therapeutic orientation and experience level of therapists may be related to patient adherence [<xref ref-type="bibr" rid="ref42">42</xref>]. Compared to busy clinic staff, full-time therapists are more likely to invest time and effort to retain and reengage patients who have discontinued treatment [32]. (4) Treatment characteristics: referring to the framework proposed by Derubeis et al [<xref ref-type="bibr" rid="ref43">43</xref>], which focuses on all factors that improve treatment and particularly on the relationship between treatment factors and outcomes. For example, this study extracted personalized feedback, real-time interaction, and therapeutic alliance. The optimization of these modifiable operational variables can directly enhance intervention effectiveness and improve patient treatment adherence [<xref ref-type="bibr" rid="ref44">44</xref>].</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Predictor variables.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Predictor category</td><td align="left" valign="bottom">Variable category</td><td align="left" valign="bottom">Variable</td><td align="left" valign="bottom">Data note</td></tr></thead><tbody><tr><td align="left" valign="top">Demographic characteristics of participants</td><td align="left" valign="top">Continuous variable</td><td align="left" valign="top">Year</td><td align="left" valign="top">Publication year</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">N<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup></td><td align="left" valign="top">Number of participants</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Age</td><td align="left" valign="top">Mean years</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Female</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">White</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">African American</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Education</td><td align="left" valign="top">&#x2266;High school degree (%)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Employed<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup></td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Unemployed<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup></td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Single/never married</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Currently single</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Married/living together</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Classified variable</td><td align="left" valign="top">Developed country<sup><xref ref-type="table-fn" rid="table1fn3">c</xref></sup></td><td align="left" valign="top">Y<sup><xref ref-type="table-fn" rid="table1fn4">d</xref></sup><sup>,</sup> N<sup><xref ref-type="table-fn" rid="table1fn5">e</xref></sup></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Low income</td><td align="left" valign="top">Y, NR<sup><xref ref-type="table-fn" rid="table1fn6">f</xref></sup></td></tr><tr><td align="left" valign="top">Baseline clinical characteristics of participants</td><td align="left" valign="top">Continuous variable</td><td align="left" valign="top">Diagnostic</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Use quantity-pre</td><td align="left" valign="top">Mean percentage of substance use quantity in the past 30 days</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Use frequency-pre</td><td align="left" valign="top">Mean percentage of substance use frequency in the past 30 days</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Use length-pre</td><td align="left" valign="top">Mean length of substance use in years at intake</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Abstinence</td><td align="left" valign="top">Percentage</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Classified variable</td><td align="left" valign="top">Inclusion criteria</td><td align="left" valign="top">Diagnostic and Statistical Manual (DSM) diagnosis, Other</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Comorbid HIV</td><td align="left" valign="top">Y, N</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Primary drug use</td><td align="left" valign="top">Cocaine, Opioids, Cannabis, ATS<sup><xref ref-type="table-fn" rid="table1fn7">g</xref></sup><sup>,</sup> Other</td></tr><tr><td align="left" valign="top">Therapist characteristics</td><td align="left" valign="top">Classified variable</td><td align="left" valign="top">Master</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Relevant experience</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Train</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Supervision</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top">Treatment characteristics</td><td align="left" valign="top">Continuous variable</td><td align="left" valign="top">Session</td><td align="left" valign="top">Number of weekly sessions</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Intervention duration</td><td align="left" valign="top">Number of weeks</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">The longest follow-up</td><td align="left" valign="top">Number of weeks</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Classified variable</td><td align="left" valign="top">Recruitment</td><td align="left" valign="top">Website, Clinic, Community, Campus, Multiple</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Compensation mode</td><td align="left" valign="top">Gift certificate, USD<sup><xref ref-type="table-fn" rid="table1fn8">h</xref></sup></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Compensation<sup><xref ref-type="table-fn" rid="table1fn9">i</xref></sup></td><td align="left" valign="top">Stepped<sup><xref ref-type="table-fn" rid="table1fn10">j</xref></sup>, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Measurement</td><td align="left" valign="top">Self-report, Toxicology, Both</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Toxicology</td><td align="left" valign="top">Y, N</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Guidance</td><td align="left" valign="top">Guided, Unguided</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Personalized feedback/intervention</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Real-time interaction</td><td align="left" valign="top">Y, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Setting</td><td align="left" valign="top">Anywhere, Laboratory</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Delivery</td><td align="left" valign="top">Computer, Telephone</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Digital media</td><td align="left" valign="top">App, Website</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Digital presentation mode</td><td align="left" valign="top">Video, Virtual character</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Fully digital</td><td align="left" valign="top">Y, N, NR</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">Assessing digital quality</td><td align="left" valign="top">Y, NR</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>N: Number.</p></fn><fn id="table1fn2"><p><sup>b</sup>&#x201C;Employed&#x201D; and &#x201C;Unemployed&#x201D;: Not complementary, they were extracted separately from different studies. We extracted only based on the study reports and did not perform back-extrapolation calculations.</p></fn><fn id="table1fn3"><p><sup>c</sup>Developed country: According to the World Health Organization.</p></fn><fn id="table1fn4"><p><sup>d</sup>Y: Yes.</p></fn><fn id="table1fn5"><p><sup>e</sup>N: No.</p></fn><fn id="table1fn6"><p><sup>f</sup>NR: Not reported.</p></fn><fn id="table1fn7"><p><sup>g</sup>ATS: Amphetamine-type stimulants.</p></fn><fn id="table1fn8"><p><sup>h</sup>USD: Use USD as experimental compensation.</p></fn><fn id="table1fn9"><p><sup>i</sup>Compensation: Refers to the monetary or nonmonetary rewards provided to study participants for their time and effort.</p></fn><fn id="table1fn10"><p><sup>j</sup>Stepped: Refers to a structured payment approach where participants receive partial rewards at different stages (eg, time-based or task-completion).</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s2-5"><title>Data Extraction</title><p>Two researchers independently extracted data using a predesigned data extraction form. Disagreements were resolved through discussion or consultation with a third researcher. This data extraction form has been piloted in some studies and adjusted according to the recommendations and structured framework of the GRADE manual. For articles that met the inclusion criteria but lacked important data, we contacted the corresponding author via email, and studies that could not provide sufficient data to calculate effect sizes were excluded.</p></sec><sec id="s2-6"><title>Quality Assessment</title><p>To assess the bias risk of the included studies, two researchers independently scored each study in five aspects using the revised Cochrane Risk of Bias tool ROB 2.0 [<xref ref-type="bibr" rid="ref45">45</xref>]: randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Any disagreements were resolved through discussion.</p></sec><sec id="s2-7"><title>Statistical Analysis and Software</title><p>We used Comprehensive Meta-Analysis software (CMA 4.0) to synthesize dropout rates across studies [<xref ref-type="bibr" rid="ref46">46</xref>]. For each trial, dropout counts and total sample sizes were extracted separately for the intervention and control groups, from which group-specific dropout proportions were calculated. To stabilize variances and account for the bounded nature of proportions, these proportions were transformed into logit event rates with corresponding standard errors, which served as the primary effect size metric. Pooled estimates were calculated separately for intervention and control groups and subsequently back-transformed into raw proportions and expressed as percentages for interpretability, an approach that has been widely applied in meta-analyses of proportion-type outcomes [<xref ref-type="bibr" rid="ref47">47</xref>]. Subsequently, between-study heterogeneity was examined using the Q statistic [<xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref>] and quantified with the I&#x00B2; statistic [<xref ref-type="bibr" rid="ref50">50</xref>]. Given the significant heterogeneity among included studies in outcome measures and moderators [<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref>], all analyses were conducted under a random-effects model [<xref ref-type="bibr" rid="ref53">53</xref>]. Publication bias was assessed using funnel plots, Egger&#x2019;s, Duval and Tweedie&#x2019;s trim and fill, and Classic fail-safe N tests [<xref ref-type="bibr" rid="ref54">54</xref>], while sensitivity analyses were conducted to evaluate the robustness of the results. To explore potential influencing factors, meta-regression and subgroup analyses were further employed to examine the association between moderators in the intervention group and dropout rate.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Characteristics of the Included Studies</title><p>After screening relevant articles based on predefined inclusion and exclusion criteria, a total of 41 studies were finally included (see <xref ref-type="fig" rid="figure1">Figure 1</xref>), involving 9693 participants with an age range of 19 to 50 years. The selection characteristics of the included studies are shown in <xref ref-type="table" rid="table2">Table 2</xref>. The studies included 82 intervention groups, with a total of 48 dropout rate data points, including 18 posttreatment dropout rates and 30 follow-up dropout rates, showing different data results between the two measurement points.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>PRISMA flow diagram of study search and selection. DPI: Digital psychosocial intervention; PRISMA: Preferred Reporting Items for Systematic reviews and Meta-Analyses; RCT: randomized controlled trial.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig01.png"/></fig><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Selected characteristics of included studies.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Author (year)</td><td align="left" valign="bottom">Country</td><td align="left" valign="bottom">N<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td><td align="left" valign="bottom">Recruitment</td><td align="left" valign="bottom">Primary substance</td><td align="left" valign="bottom">Intervention type</td><td align="left" valign="bottom">Age, M (SD)</td><td align="left" valign="bottom">F (%)</td><td align="left" valign="bottom">Intervention duration<break/>(wk&#xFF09;</td><td align="left" valign="bottom">Sessions</td><td align="left" valign="bottom">The longest follow-up (wk)</td></tr></thead><tbody><tr><td align="left" valign="top">Aharonovich (2012)[<xref ref-type="bibr" rid="ref55">55</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">40</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cocaine/crack (75.8%)</td><td align="left" valign="top">MI<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup>+BI<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">45.5 (6.6)</td><td align="left" valign="top">24.2</td><td align="left" valign="top">8</td><td align="left" valign="top">7.00</td><td align="left" valign="top">NR<sup><xref ref-type="table-fn" rid="table2fn4">d</xref></sup></td></tr><tr><td align="left" valign="top">Aharonovich (2017a)[<xref ref-type="bibr" rid="ref56">56</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">240</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI+BI</td><td align="left" valign="top">46.5 (9.3)</td><td align="left" valign="top">16.3</td><td align="left" valign="top">8.57</td><td align="left" valign="top">7.00</td><td align="left" valign="top">48</td></tr><tr><td align="left" valign="top">Aharonovich (2017b)[<xref ref-type="bibr" rid="ref57">57</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">47</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Crack (91.49%)</td><td align="left" valign="top">MI+BI</td><td align="left" valign="top">50.9 (7.0)</td><td align="left" valign="top">23.4</td><td align="left" valign="top">8.57</td><td align="left" valign="top">7.00</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Baumgartner (2021)[<xref ref-type="bibr" rid="ref58">58</xref>]</td><td align="left" valign="top">Switzerland, Austria, Germany, Other (0.7%)</td><td align="left" valign="top">575</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">CBT<sup><xref ref-type="table-fn" rid="table2fn5">e</xref></sup>+MI+BI</td><td align="left" valign="top">28.3 (7.9)</td><td align="left" valign="top">29.4</td><td align="left" valign="top">6</td><td align="left" valign="top">NR</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Blow (2017)[<xref ref-type="bibr" rid="ref59">59</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">780</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cannabis (91.1%)</td><td align="left" valign="top">MI</td><td align="left" valign="top">31.2 (10.9)</td><td align="left" valign="top">55.5</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Bonar (2022)[<xref ref-type="bibr" rid="ref60">60</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">149</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">CBT+MI</td><td align="left" valign="top">21 (2.2)</td><td align="left" valign="top">55.7</td><td align="left" valign="top">8</td><td align="left" valign="top">7.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Bonar (2023)[<xref ref-type="bibr" rid="ref61">61</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">58</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">MI</td><td align="left" valign="top">21.5 (2.4)</td><td align="left" valign="top">65.5</td><td align="left" valign="top">4</td><td align="left" valign="top">7.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Brooks (2010)[<xref ref-type="bibr" rid="ref62">62</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">28</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cocaine</td><td align="left" valign="top">CRA<sup><xref ref-type="table-fn" rid="table2fn6">f</xref></sup></td><td align="left" valign="top">43.1 (9.2)</td><td align="left" valign="top">55</td><td align="left" valign="top">8</td><td align="left" valign="top">3.00</td><td align="left" valign="top">10</td></tr><tr><td align="left" valign="top">Buckner (2020)[<xref ref-type="bibr" rid="ref63">63</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">63</td><td align="left" valign="top">Campus</td><td align="left" valign="top">cannabis</td><td align="left" valign="top">BI</td><td align="left" valign="top">19.1 (1.5)</td><td align="left" valign="top">84.1</td><td align="left" valign="top">64</td><td align="left" valign="top">1</td><td align="left" valign="top">2</td></tr><tr><td align="left" valign="top">Budney (2011)[<xref ref-type="bibr" rid="ref64">64</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">38</td><td align="left" valign="top">Community</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">MET<sup><xref ref-type="table-fn" rid="table2fn7">g</xref></sup>+ CBT+CM<sup><xref ref-type="table-fn" rid="table2fn8">h</xref></sup></td><td align="left" valign="top">32.8 (9.7)</td><td align="left" valign="top">47.1</td><td align="left" valign="top">12</td><td align="left" valign="top">1.00</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Budney (2015)[<xref ref-type="bibr" rid="ref65">65</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">75</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">MET+ CBT+CM</td><td align="left" valign="top">35.9 (10.5)</td><td align="left" valign="top">43</td><td align="left" valign="top">12</td><td align="left" valign="top">2.00</td><td align="left" valign="top">36</td></tr><tr><td align="left" valign="top">Campbell (2014)[<xref ref-type="bibr" rid="ref66">66</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">507</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">CRA+CM</td><td align="left" valign="top">34.9 (10.9)</td><td align="left" valign="top">37.9</td><td align="left" valign="top">12</td><td align="left" valign="top">4.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Carroll (2014)[<xref ref-type="bibr" rid="ref67">67</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">101</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cocaine (100%)</td><td align="left" valign="top">CBT</td><td align="left" valign="top">41.9 (9.6)</td><td align="left" valign="top">60.4</td><td align="left" valign="top">8</td><td align="left" valign="top">7.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Chopra (2009)[<xref ref-type="bibr" rid="ref68">68</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">120</td><td align="left" valign="top">Community</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">CRA+CM</td><td align="left" valign="top">31.8 (10.5)</td><td align="left" valign="top">42.5</td><td align="left" valign="top">12</td><td align="left" valign="top">3.00</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Christensen (2014)[<xref ref-type="bibr" rid="ref69">69</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">170</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">CRA+CM</td><td align="left" valign="top">34.3 (10.8)</td><td align="left" valign="top">45.9</td><td align="left" valign="top">12</td><td align="left" valign="top">3.00</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Christoff (2015)[<xref ref-type="bibr" rid="ref25">25</xref>]</td><td align="left" valign="top">Brazil</td><td align="left" valign="top">458</td><td align="left" valign="top">Campus</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI</td><td align="left" valign="top">24 (5.4)</td><td align="left" valign="top">7</td><td align="left" valign="top">0.14</td><td align="left" valign="top">1.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Chun-Hung (2023)[<xref ref-type="bibr" rid="ref70">70</xref>]</td><td align="left" valign="top">Taiwan, China</td><td align="left" valign="top">99</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">ATS<sup><xref ref-type="table-fn" rid="table2fn9">i</xref></sup> (100%)</td><td align="left" valign="top">MBRP<sup><xref ref-type="table-fn" rid="table2fn10">j</xref></sup></td><td align="left" valign="top">37 (10.4)</td><td align="left" valign="top">18.2</td><td align="left" valign="top">NR</td><td align="left" valign="top">4.20</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Conner (2024)[<xref ref-type="bibr" rid="ref71">71</xref>]</td><td align="left" valign="top">Canada, USA</td><td align="left" valign="top">781</td><td align="left" valign="top">Campus</td><td align="left" valign="top">Cannabis</td><td align="left" valign="top">BI</td><td align="left" valign="top">21.7 (2.8)</td><td align="left" valign="top">39.7</td><td align="left" valign="top">0.14</td><td align="left" valign="top">1</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top">Coronado-Montoya (2025)[<xref ref-type="bibr" rid="ref72">72</xref>]</td><td align="left" valign="top">Canada</td><td align="left" valign="top">101</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">CBT+MI</td><td align="left" valign="top">25.2 (3.9)</td><td align="left" valign="top">18.8</td><td align="left" valign="top">6</td><td align="left" valign="top">1</td><td align="left" valign="top">18</td></tr><tr><td align="left" valign="top">Dunn (2017)[<xref ref-type="bibr" rid="ref73">73</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">76</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">PE<sup><xref ref-type="table-fn" rid="table2fn11">k</xref></sup></td><td align="left" valign="top">39.9 (12.7)</td><td align="left" valign="top">40.8</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Elliott (2014)[<xref ref-type="bibr" rid="ref74">74</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">162</td><td align="left" valign="top">Campus</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">PE</td><td align="left" valign="top">19.3 (1.2)</td><td align="left" valign="top">52</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top">Glasner (2022)[<xref ref-type="bibr" rid="ref75">75</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">54</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Opioid (50%), ATS (50%)</td><td align="left" valign="top">CBT</td><td align="left" valign="top">47.7 (8.2)</td><td align="left" valign="top">20</td><td align="left" valign="top">12</td><td align="left" valign="top">7.00</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Gryczynski (2015)[<xref ref-type="bibr" rid="ref76">76</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">360</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI</td><td align="left" valign="top">36.2 (14.6)</td><td align="left" valign="top">46</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">48</td></tr><tr><td align="left" valign="top">Gryczynski (2016)[<xref ref-type="bibr" rid="ref77">77</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">80</td><td align="left" valign="top">Community</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI</td><td align="left" valign="top">35 (13)</td><td align="left" valign="top">53</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Gustafson (2024)[<xref ref-type="bibr" rid="ref78">78</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">414</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Opioid</td><td align="left" valign="top">PE+BI+MI</td><td align="left" valign="top">37.2 (10.0)</td><td align="left" valign="top">45.2</td><td align="left" valign="top">64</td><td align="left" valign="top">NR</td><td align="left" valign="top">32</td></tr><tr><td align="left" valign="top">Ingersoll (2011)[<xref ref-type="bibr" rid="ref79">79</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">56</td><td align="left" valign="top">Community</td><td align="left" valign="top">Crack cocaine (100%)</td><td align="left" valign="top">PE</td><td align="left" valign="top">45 (6.4)</td><td align="left" valign="top">51.9</td><td align="left" valign="top">8</td><td align="left" valign="top">0.75</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Maricich (2021)[<xref ref-type="bibr" rid="ref80">80</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">170</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">CRA</td><td align="left" valign="top">32.9 (9.8)</td><td align="left" valign="top">45.9</td><td align="left" valign="top">12</td><td align="left" valign="top">2.50</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Marsch (2014)[<xref ref-type="bibr" rid="ref81">81</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">160</td><td align="left" valign="top">Community</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">CRA+CBT</td><td align="left" valign="top">40.7 (9.8)</td><td align="left" valign="top">25</td><td align="left" valign="top">48</td><td align="left" valign="top">0.54</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Moore (2019)[<xref ref-type="bibr" rid="ref82">82</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">82</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">CBT</td><td align="left" valign="top">42.4 (10.9)</td><td align="left" valign="top">40.2</td><td align="left" valign="top">12</td><td align="left" valign="top">7.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Olthof (2023)[<xref ref-type="bibr" rid="ref83">83</xref>]</td><td align="left" valign="top">Netherlands</td><td align="left" valign="top">378</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">CBT+MI</td><td align="left" valign="top">27.5 (8.5)</td><td align="left" valign="top">30.7</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Ondersma (2007)[<xref ref-type="bibr" rid="ref84">84</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">107</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI</td><td align="left" valign="top">25.1 (5.6)</td><td align="left" valign="top">100</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Ondersma (2014)[<xref ref-type="bibr" rid="ref85">85</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">143</td><td align="left" valign="top">Clinic</td><td align="left" valign="top">Any</td><td align="left" valign="top">MI</td><td align="left" valign="top">26.6 (6)</td><td align="left" valign="top">100.0</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Schaub (2019)[<xref ref-type="bibr" rid="ref86">86</xref>]</td><td align="left" valign="top">Switzerland</td><td align="left" valign="top">311</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">PE+CBT+MI</td><td align="left" valign="top">33.1 (7.6)</td><td align="left" valign="top">27</td><td align="left" valign="top">6</td><td align="left" valign="top">1.50</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Schaub (2015)[<xref ref-type="bibr" rid="ref87">87</xref>]</td><td align="left" valign="top">Switzerland</td><td align="left" valign="top">308</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">CBT+MI</td><td align="left" valign="top">29.8 (10)</td><td align="left" valign="top">24.7</td><td align="left" valign="top">6</td><td align="left" valign="top">NR</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Schwartz (2014)[<xref ref-type="bibr" rid="ref88">88</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">360</td><td align="left" valign="top">Community</td><td align="left" valign="top">Cannabis (88%)</td><td align="left" valign="top">BI</td><td align="left" valign="top">36.1 (14.6)</td><td align="left" valign="top">46</td><td align="left" valign="top">1</td><td align="left" valign="top">1.00</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Shi (2019)[<xref ref-type="bibr" rid="ref89">89</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">20</td><td align="left" valign="top">Community</td><td align="left" valign="top">Opioid (100%)</td><td align="left" valign="top">CBT</td><td align="left" valign="top">40.5 (12.2)</td><td align="left" valign="top">40</td><td align="left" valign="top">12</td><td align="left" valign="top">6.88</td><td align="left" valign="top">NR</td></tr><tr><td align="left" valign="top">Sinadinovic (2020)[<xref ref-type="bibr" rid="ref90">90</xref>]</td><td align="left" valign="top">Sweden</td><td align="left" valign="top">303</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">PE+CBT+MI</td><td align="left" valign="top">27.4 (7.2)</td><td align="left" valign="top">32.7</td><td align="left" valign="top">6</td><td align="left" valign="top">1.50</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Tait (2015)[<xref ref-type="bibr" rid="ref91">91</xref>]</td><td align="left" valign="top">Australia</td><td align="left" valign="top">160</td><td align="left" valign="top">Multiple</td><td align="left" valign="top">ATS (100%)</td><td align="left" valign="top">CBT+MI</td><td align="left" valign="top">22.4 (6.3)</td><td align="left" valign="top">24</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">24</td></tr><tr><td align="left" valign="top">Tossmann (2011)[<xref ref-type="bibr" rid="ref92">92</xref>]</td><td align="left" valign="top">Germany</td><td align="left" valign="top">1292</td><td align="left" valign="top">Website</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">SFBT<sup><xref ref-type="table-fn" rid="table2fn12">l</xref></sup></td><td align="left" valign="top">24.7 (6.8)</td><td align="left" valign="top">29.5</td><td align="left" valign="top">7.14</td><td align="left" valign="top">NR</td><td align="left" valign="top">12</td></tr><tr><td align="left" valign="top">Walukevich-Dienst (2019)[<xref ref-type="bibr" rid="ref93">93</xref>]</td><td align="left" valign="top">USA</td><td align="left" valign="top">227</td><td align="left" valign="top">Campus</td><td align="left" valign="top">Cannabis (100%)</td><td align="left" valign="top">PE</td><td align="left" valign="top">19.8 (1.4)</td><td align="left" valign="top">77</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">4</td></tr><tr><td align="left" valign="top">Xu (2021)[<xref ref-type="bibr" rid="ref94">94</xref>]</td><td align="left" valign="top">China</td><td align="left" valign="top">40</td><td align="left" valign="top">Community</td><td align="left" valign="top">ATS (&#x003E;90%)</td><td align="left" valign="top">PE+ST<sup><xref ref-type="table-fn" rid="table2fn13">m</xref></sup></td><td align="left" valign="top">46.1 (9.9)</td><td align="left" valign="top">22.5</td><td align="left" valign="top">NR</td><td align="left" valign="top">1.00</td><td align="left" valign="top">24</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>N: Number of participants.</p></fn><fn id="table2fn2"><p><sup>b</sup>MI: Motivational interviewing.</p></fn><fn id="table2fn3"><p><sup>c</sup>BI: Brief intervention.</p></fn><fn id="table2fn4"><p><sup>d</sup>NR: Not reported.</p></fn><fn id="table2fn5"><p><sup>e</sup>CBT: Cognitive behavior therapy.</p></fn><fn id="table2fn6"><p><sup>f</sup>CRA: Community reinforcement approach.</p></fn><fn id="table2fn7"><p><sup>g</sup>MET: Motivational enhancement therapy.</p></fn><fn id="table2fn8"><p><sup>h</sup>CM: Contingency management.</p></fn><fn id="table2fn9"><p><sup>i</sup>ATS: Amphetamine-type stimulants.</p></fn><fn id="table2fn10"><p><sup>j</sup>MBRP: Mindfulness-based relapse prevention.</p></fn><fn id="table2fn11"><p><sup>k</sup>PE: Psychoeducation.</p></fn><fn id="table2fn12"><p><sup>l</sup>SFBT: Solution-focused brief therapy.</p></fn><fn id="table2fn13"><p><sup>m</sup>ST: Support.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Risk of Bias Assessment</title><p>The risk of bias in the included studies was assessed using the Cochrane Risk of Bias tool (ROB 2.0). Detailed results and percentage plots are presented in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>. The results showed that approximately 90% of the included studies had a low risk in terms of the randomization process (D1), measurement of the outcome (D4), and selection of the reported result (D5). Approximately 55% of the included studies had some concerns about deviations from intended intervention (D2). About 50% of the studies had a high risk of missing outcome data (D3), which is a key focus of our research.</p></sec><sec id="s3-3"><title>Meta-Analysis Results</title><sec id="s3-3-1"><title>Posttreatment</title><p>An analysis of 18 studies was conducted using a random-effects model. The main effect results (<xref ref-type="fig" rid="figure2">Figure 2</xref>) showed that the mean dropout rate in the intervention group was 22% (95% CI 0.13&#x2010;0.36), lower than that in the control group of 26% (95% CI 0.16&#x2010;0.39) [<xref ref-type="bibr" rid="ref51">51</xref>]. However, heterogeneity testing indicated high variability among the studies (Q=396.18, <italic>df</italic>=17, <italic>P</italic>&#x003C;.001; I&#x00B2;=96%). Further analysis revealed that the variance of the true effect size reached 2.02 (logit units) with a standard deviation of 1.42 (logit units).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Forest plot of dropout rate in the intervention group at posttreatment [<xref ref-type="bibr" rid="ref55">55</xref>-<xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref64">64</xref>-<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref80">80</xref>-<xref ref-type="bibr" rid="ref82">82</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref89">89</xref>].</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig02.png"/></fig><p>Meta-regression and subgroup analysis revealed that this extreme variability was primarily due to four variables among three categories (<xref ref-type="table" rid="table3">Table 3</xref>): (1) Participant demographic characteristics: The proportion with employment rate showed a weak positive correlation with dropout rate (OR 1.04, 95% CI 1.00&#x2010;1.07; <italic>P</italic>=.03). (2) Participant clinical characteristics: Participants with baseline clinical diagnoses showed a significant positive correlation with dropout rate (odds ratio [OR] 1.03, 95% CI 1.01&#x2010;1.06; <italic>P</italic>=.01). The dropout rate for those using cocaine as the baseline primary medication (OR 1.96, 95% CI 0.31&#x2010;12.57; <italic>P</italic>=.48) was significantly higher than that for those using cannabis and opioid medications. (3) Intervention characteristics: Intervention frequency showed a significant negative correlation with dropout rate (OR 0.77, 95% CI 0.60&#x2010;0.99; <italic>P</italic>=.04). The other 27 factors showed no significant correlation with dropout rate.</p><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Meta-regressions and subgroup analysis in the intervention group at posttreatment.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Predictor category</td><td align="left" valign="bottom">Predictor/Predictor value</td><td align="left" valign="bottom">Studies</td><td align="left" valign="bottom">Coefficient</td><td align="left" valign="bottom">Standard error</td><td align="left" valign="bottom">Dropout (95% CI)</td><td align="left" valign="bottom">z-value</td><td align="left" valign="bottom">2-sided <italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top">Demographic characteristics of participants</td><td align="left" valign="top">Employed</td><td align="left" valign="top">6</td><td align="left" valign="top">0.0348</td><td align="left" valign="top">0.0159</td><td align="left" valign="top">0.0036 to 0.0661</td><td align="left" valign="top">&#x2003;2.19</td><td align="left" valign="top">.0288</td></tr><tr><td align="left" valign="top">Baseline clinical characteristics of participants</td><td align="left" valign="top">Diagnostic</td><td align="left" valign="top">12</td><td align="left" valign="top">0.0305</td><td align="left" valign="top">0.0125</td><td align="left" valign="top">0.0060 to 0.0549</td><td align="left" valign="top">&#x2003;2.44</td><td align="left" valign="top">.0145</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Primary drug use</td><td align="left" valign="top">17</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top">.0190</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cocaine</td><td align="left" valign="top">3</td><td align="left" valign="top">0.6738</td><td align="left" valign="top">0.9478</td><td align="left" valign="top">&#x2212;1.1838 to 2.5314</td><td align="left" valign="top">&#x2003;0.71</td><td align="left" valign="top">.4771</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Opioid</td><td align="left" valign="top">5</td><td align="left" valign="top">&#x2212;0.2639</td><td align="left" valign="top">0.8303</td><td align="left" valign="top">&#x2212;1.8912 to 1.3634</td><td align="left" valign="top">&#x2212;0.32</td><td align="left" valign="top">.7506</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cannabis</td><td align="left" valign="top">5</td><td align="left" valign="top">&#x2212;0.7448</td><td align="left" valign="top">0.5838</td><td align="left" valign="top">&#x2212;1.8889 to 0.3994</td><td align="left" valign="top">&#x2212;1.28</td><td align="left" valign="top">.2020</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">4</td><td align="left" valign="top">&#x2212;2.2799</td><td align="left" valign="top">0.9056</td><td align="left" valign="top">&#x2212;4.0548 to &#x2212;0.5050</td><td align="left" valign="top">&#x2212;2.52</td><td align="left" valign="top">.0118</td></tr><tr><td align="left" valign="top">Treatment characteristics</td><td align="left" valign="top">Session</td><td align="left" valign="top">17</td><td align="left" valign="top">&#x2212;0.2609</td><td align="left" valign="top">0.1266</td><td align="left" valign="top">-0.5090 to &#x2212;0.0127</td><td align="left" valign="top">&#x2212;2.06</td><td align="left" valign="top">.0394</td></tr></tbody></table></table-wrap><p>The funnel plot showed some studies beyond the expected range (<xref ref-type="fig" rid="figure3">Figure 3</xref>), suggesting the presence of studies with extreme dropout rates. Combined with Egger&#x2019;s test results (<italic>P</italic>&#x003C;.001), this further confirmed the presence of publication bias. After trimming the 5 missing studies on the right side, the effect size was adjusted from 22% to 33%, still not crossing the clinical threshold. Further leave-one-out analysis showed that 366 unpublished studies would need to be included to make the current result statistically insignificant. Overall, the results indicate that despite publication bias, the adjusted effect size did not exceed the clinical threshold and the leave-one-out number was high, supporting the stability of the study conclusions. Sensitivity analysis also showed (<xref ref-type="fig" rid="figure4">Figure 4</xref>) that removing any single study would not change the overall trend.</p><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>The funnel plot for dropout rate in the intervention group at posttreatment.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig03.png"/></fig><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>Sensitivity analysis for dropout rate in the intervention group at posttreatment [<xref ref-type="bibr" rid="ref55">55</xref>-<xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref64">64</xref>-<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref80">80</xref>-<xref ref-type="bibr" rid="ref82">82</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref89">89</xref>].</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig04.png"/></fig></sec></sec><sec id="s3-4"><title>The Longest Follow-Up</title><p>Follow-up analysis of the intervention group was based on 30 studies, with an average dropout rate of 28.2% (95% CI 0.19&#x2010;0.39) (<xref ref-type="fig" rid="figure5">Figure 5</xref>), while the rate in the control group was 27.8% (95% CI 0.20&#x2010;0.37). However, heterogeneity testing again indicated high variability among the studies (Q=1293.13, <italic>df</italic>=29, <italic>P</italic>=.000, I&#x00B2;=98%). Further analysis revealed that the variance of the true effect size reached 1.79 (logit units) with a standard deviation of 1.34 (logit units).</p><fig position="float" id="figure5"><label>Figure 5.</label><caption><p>Forest plot of dropout rate in the intervention group at the longest follow-up [<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref58">58</xref>-<xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref70">70</xref>-<xref ref-type="bibr" rid="ref74">74</xref>,<xref ref-type="bibr" rid="ref76">76</xref>-<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref83">83</xref>-<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref90">90</xref>-<xref ref-type="bibr" rid="ref94">94</xref>].</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig05.png"/></fig><p>Meta-regression analysis and subgroup analysis (<xref ref-type="table" rid="table4">Table 4</xref>) revealed that this extreme variability is primarily due to 4 variables among three types of characteristics: (1) participant characteristics: dropout rate showed a negative correlation with single status (OR 0.95, 95% CI 0.91&#x2010;0.99; <italic>P</italic>=.01); (2) clinical characteristics: significantly positive correlation with baseline medication frequency (OR 1.18, 95% CI 1.05&#x2010;1.32; <italic>P</italic>=.004); (3) intervention characteristics: participants recruited via website showed a positive correlation with dropout rate (OR 5.74, 95% CI 1.85&#x2010;17.76; <italic>P</italic>=.002), while participants recruited via campus showed a negative correlation with dropout rate (OR 0.28, 95% CI 0.12&#x2010;0.66; <italic>P</italic>=.003); The association between the degree of digitalization and dropout rates varied depending on whether studies with unreported digitalization status (not reported [NR] group) were included. When all studies, including the NR group, were analyzed, the overall model reached statistical significance (Q=28.13, <italic>df</italic>=2, <italic>P</italic>&#x003C;.001), with the NR group showing a strongly significant negative effect (OR 0.16, 95% CI 0.06&#x2010;0.41; <italic>P</italic>&#x003C;.001). However, when the NR group was excluded and only studies explicitly reporting &#x201C;fully digital&#x201D; or &#x201C;partially digital&#x201D; were considered, the results were not statistically significant (Q=0.24, <italic>P</italic>=.62). The other 32 factors showed no significant correlation with dropout rate.</p><table-wrap id="t4" position="float"><label>Table 4.</label><caption><p>Meta-regression and subgroup analysis in the intervention group at the longest follow-up.</p></caption><table id="table4" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Predictor category</td><td align="left" valign="bottom">Predictor/Predictor value</td><td align="left" valign="bottom">Studies</td><td align="left" valign="bottom">Coefficient</td><td align="left" valign="bottom">Standard error</td><td align="left" valign="bottom">Dropout (95% CI)</td><td align="left" valign="bottom">z-value</td><td align="left" valign="bottom">2-sided <italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top">Demographic characteristics of participants</td><td align="left" valign="top">Currently single</td><td align="left" valign="top">10</td><td align="left" valign="top">&#x2212;0.0528</td><td align="left" valign="top">0.0214</td><td align="left" valign="top">&#x2212;0.0947 to &#x2212;0.0108</td><td align="left" valign="top">&#x2212;2.47</td><td align="left" valign="top">.0136</td></tr><tr><td align="left" valign="top">Baseline clinical characteristics of participants</td><td align="left" valign="top">Use frequency-pre</td><td align="left" valign="top">10</td><td align="left" valign="top">&#x2003;0.1657</td><td align="left" valign="top">0.0576</td><td align="left" valign="top">&#x2003;0.0528 to 0.2786</td><td align="left" valign="top">&#x2003;2.88</td><td align="left" valign="top">.0040</td></tr><tr><td align="left" valign="top">Treatment characteristics</td><td align="left" valign="top">Recruitment</td><td align="left" valign="top">28</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Website</td><td align="left" valign="top">6</td><td align="left" valign="top">&#x2003;1.7478</td><td align="left" valign="top">0.5762</td><td align="left" valign="top">&#x2003;0.6168 to 2.8770</td><td align="left" valign="top">&#x2003;3.03</td><td align="left" valign="top">.0024</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Clinic</td><td align="left" valign="top">12</td><td align="left" valign="top">&#x2003;0.0973</td><td align="left" valign="top">0.5204</td><td align="left" valign="top">&#x2212;0.9225 to 1.1172</td><td align="left" valign="top">&#x2003;0.19</td><td align="left" valign="top">.8516</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Campus</td><td align="left" valign="top">5</td><td align="left" valign="top">&#x2212;1.2797</td><td align="left" valign="top">0.4371</td><td align="left" valign="top">&#x2212;2.1365 to &#x2212;0.4230</td><td align="left" valign="top">&#x2212;2.93</td><td align="left" valign="top">.0034</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Community</td><td align="left" valign="top">5</td><td align="left" valign="top">&#x2212;0.8413</td><td align="left" valign="top">0.6384</td><td align="left" valign="top">&#x2212;2.0924 to 0.4099</td><td align="left" valign="top">&#x2212;1.32</td><td align="left" valign="top">.1875</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Fully digital</td><td align="left" valign="top">30</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>No</td><td align="left" valign="top">4</td><td align="left" valign="top">&#x2003;0.5442</td><td align="left" valign="top">0.4530</td><td align="left" valign="top">&#x2212;0.3437 to 1.4320</td><td align="left" valign="top">&#x2003;1.20</td><td align="left" valign="top">.2297</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Yes</td><td align="left" valign="top">3</td><td align="left" valign="top">&#x2003;0.2858</td><td align="left" valign="top">0.6540</td><td align="left" valign="top">&#x2212;0.9960 to 1.5676</td><td align="left" valign="top">&#x2003;0.44</td><td align="left" valign="top">.6621</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not reported</td><td align="left" valign="top">23</td><td align="left" valign="top">&#x2212;1.8401</td><td align="left" valign="top">0.4882</td><td align="left" valign="top">&#x2212;2.7970 to &#x2212;0.8831</td><td align="left" valign="top">&#x2212;3.77</td><td align="left" valign="top">.0002</td></tr></tbody></table></table-wrap><p>The funnel plot showed some studies beyond the expected range (see <xref ref-type="fig" rid="figure6">Figure 6</xref>). Combined with Egger test results (<italic>P</italic>=.023), publication bias was further confirmed. After trimming the six missing studies on the right side, the effect size changed from 28% to 37% after correction, without crossing the clinical threshold. Further leave-one-out sensitivity analysis showed that 1244 unpublished studies would need to be included to make the current results statistically insignificant, supporting the stability of the research conclusion. Meanwhile, sensitivity analysis (see <xref ref-type="fig" rid="figure7">Figure 7</xref>) indicated that the results of this study were robust and not dependent on individual studies.</p><fig position="float" id="figure6"><label>Figure 6.</label><caption><p>The funnel plot for dropout rate in the intervention group at the longest follow-up.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig06.png"/></fig><fig position="float" id="figure7"><label>Figure 7.</label><caption><p>Sensitivity analysis for dropout rate in the intervention group at the longest follow-up [<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref58">58</xref>-<xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref70">70</xref>-<xref ref-type="bibr" rid="ref74">74</xref>,<xref ref-type="bibr" rid="ref76">76</xref>-<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref83">83</xref>-<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref90">90</xref>-<xref ref-type="bibr" rid="ref94">94</xref>].</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v27i1e77853_fig07.png"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>This meta-analysis systematically evaluated the treatment retention effect of digital psychosocial interventions among adult illicit drug users. The pooled dropout rate was 22%, slightly lower than the approximately 30% reported for face-to-face psychosocial interventions [<xref ref-type="bibr" rid="ref37">37</xref>], suggesting potential advantages of digital formats for treatment retention. Nevertheless, the substantial heterogeneity across studies limits the generalizability of these findings. Dropout rates also varied across settings and populations. For instance, adults with co-occurring severe mental disorders and substance use had an average dropout of 27% [<xref ref-type="bibr" rid="ref95">95</xref>], whereas clinical samples of opioid users showed rates as high as 41% [<xref ref-type="bibr" rid="ref73">73</xref>]. Beyond dropout, adherence constitutes another key indicator of engagement, with evidence showing that participants completed, on average, 60% of digital intervention modules, and only about half finished the full program [<xref ref-type="bibr" rid="ref96">96</xref>]. Taken together, these results underscore the importance of considering both dropout and adherence when evaluating intervention effectiveness. Building on this, our moderator analyses further revealed complex interactive effects. To ensure clarity, we retained the classification system established during data extraction, presenting results separately across four major categories of characteristics as well as between short-term and longest intervention stages.</p><p>At the posttreatment stage, dropout was significantly influenced by participants&#x2019; demographic, intervention, and clinical characteristics. Regarding demographics, unemployment did not predict dropout, whereas higher employment was unexpectedly associated with greater attrition. This suggests that unstable or high-intensity work may interfere with regular participation. In addition, the short-term income from employment may reduce some patients&#x2019; motivation for treatment, especially when symptoms temporarily improve, leading them to discontinue prematurely due to &#x201C;feeling better&#x201D; [<xref ref-type="bibr" rid="ref97">97</xref>]. For intervention characteristics, intervention frequency showed a negative correlation with dropout, indicating that more frequent contact may help consolidate behavior change, strengthen the therapeutic alliance, and enhance commitment [<xref ref-type="bibr" rid="ref98">98</xref>-<xref ref-type="bibr" rid="ref100">100</xref>]. Future studies should explore the optimal intervention frequency under different conditions [<xref ref-type="bibr" rid="ref101">101</xref>], balancing treatment intensity with patient burden [<xref ref-type="bibr" rid="ref102">102</xref>].</p><p>The results of baseline clinical characteristics indicated that both baseline clinical diagnosis and baseline cocaine use were significantly positively associated with dropout rates. Specifically, patients with a clear baseline diagnosis were at greater risk of dropout due to challenges such as dependency, withdrawal symptoms, and impaired cognitive or emotional functioning [<xref ref-type="bibr" rid="ref42">42</xref>]. For this population, the integration of adjunctive pharmacological or behavioral therapies is recommended to reduce dropout [<xref ref-type="bibr" rid="ref103">103</xref>]. Furthermore, consistent with previous findings [<xref ref-type="bibr" rid="ref32">32</xref>], participants with baseline cocaine use were more likely to discontinue treatment. Cocaine use disorder is often closely linked to impulsive behavior and diminished adherence [<xref ref-type="bibr" rid="ref37">37</xref>]. These substance-specific risks highlight the importance of developing differentiated intervention strategies tailored to distinct types of substance use in future research [<xref ref-type="bibr" rid="ref104">104</xref>]. Nevertheless, the small sample size of drug-use subgroups (k&#x2264;5) remains a limitation, which could be addressed through multi-institutional collaborations to expand subgroup samples.</p><p>During the longest follow-up, dropout was significantly influenced by demographic, clinical, and intervention characteristics. In demographics, a higher proportion of single participants was linked to lower dropout. This may be related to reduced drug exposure in family environments [<xref ref-type="bibr" rid="ref105">105</xref>-<xref ref-type="bibr" rid="ref107">107</xref>]. In addition, single participants with low social support were more likely to continue seeking health information online. Future research could involve non&#x2013;drug-using significant others in monitoring the intervention process and integrate peer support modules [<xref ref-type="bibr" rid="ref108">108</xref>]. In clinical characteristics, participants with higher baseline drug use frequency faced markedly greater dropout risk. This finding is consistent with recent studies [<xref ref-type="bibr" rid="ref109">109</xref>]. For this high-risk group, we recommend the implementation of multistage intensive intervention programs [<xref ref-type="bibr" rid="ref110">110</xref>], together with the development of immediate-response modules (eg, crisis management tools, real-time consultation functions) to reduce early dropout [<xref ref-type="bibr" rid="ref81">81</xref>].</p><p>In terms of intervention characteristics, participants recruited through websites exhibited higher dropout rates, whereas those recruited from campus showed lower dropout rates. This may be explained by the lack of intensive treatment services typically provided in clinical settings, as well as the relative stability of campus environments [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref111">111</xref>]. Based on this finding, we recommend adopting a mixed online&#x2013;offline recruitment strategy [<xref ref-type="bibr" rid="ref112">112</xref>]. In addition, intervention content should be optimized for online recruits [<xref ref-type="bibr" rid="ref113">113</xref>], including simplifying operational procedures, providing regular reminders, and offering personalized feedback. The study also analyzed the association between the degree of digitalization and dropout rates. During data processing, studies that did not report their digitalization status (23/30, 77%) were categorized separately as a &#x201C;Not reported&#x201D; group for analysis rather than being directly excluded. The analysis revealed a significant association: compared to the nonsignificant negative correlation between fully digital interventions and dropout rates, interventions with unreported digitalization status showed a significant negative correlation, while non-fully digital interventions demonstrated a significant positive correlation with dropout rates. However, the reliability of these subgroup comparisons is constrained by the prevalent issue of poorly reported data. When we excluded the &#x201C;Not reported&#x201D; studies and repeated the analysis, no significant differences were found between fully digital and partially digital interventions. This suggests that the initial findings were likely confounded by nonrandom reporting bias rather than reflecting true effects, making definitive evaluation difficult. Therefore, these results primarily highlight the urgent need for future research to standardize the reporting of specific digital intervention details in order to more reliably explore the role of digitalization degree and human support in improving retention rates [<xref ref-type="bibr" rid="ref114">114</xref>].</p></sec><sec id="s4-2"><title>Research Significance</title><p>This study systematically evaluated the dropout rate and its predictive factors among adult illicit drug users in digital psychological interventions, thereby addressing a critical research gap in the field. Unlike previous studies that primarily focused on demographic characteristics, this analysis incorporated multidimensional predictive variables&#x2014;including clinical features, therapist-related factors, and intervention characteristics&#x2014;to establish a more systematic theoretical framework. The identification of eight key predictive factors provides valuable insights for personalized interventions, guiding the development of tailored digital tools for patients at high risk of dropout. Optimization strategies derived from this evidence are expected to substantially reduce dropout rates and enhance intervention effectiveness [<xref ref-type="bibr" rid="ref30">30</xref>].</p></sec><sec id="s4-3"><title>Limitations and Future Research</title><p>This study has several limitations. First, few of the included trials provided detailed information on software quality or reasons for dropout, which limited our ability to assess the reasons why participants stopped treatment [<xref ref-type="bibr" rid="ref115">115</xref>]. Future studies could combine machine learning methods to predict dropout risk [<xref ref-type="bibr" rid="ref116">116</xref>] and use participant-centered questionnaires to collect data on perceived barriers. Previous research [<xref ref-type="bibr" rid="ref117">117</xref>-<xref ref-type="bibr" rid="ref120">120</xref>] emphasized common reasons for dropout, including technical difficulties, lack of engagement, and perceived ineffectiveness of the intervention. Collaboration with software engineers may help optimize the digital experience and reduce technical-related attrition [<xref ref-type="bibr" rid="ref121">121</xref>]. Additionally, methodological improvements, such as combining intention-to-treat analysis with run-in phase dropout screening [<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref122">122</xref>], may provide more refined methods for managing early dropout.</p><p>Second, most of the digital interventions included in the studies adopted limited forms, such as videos, virtual characters, or text messages, and lacked interactive features. Incorporating gamification elements may enhance user engagement [<xref ref-type="bibr" rid="ref123">123</xref>], especially when personalized to individual preferences [<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref121">121</xref>]. Emerging evidence suggests that well-designed therapeutic video games can improve cognitive and mental health outcomes [<xref ref-type="bibr" rid="ref121">121</xref>], even inducing neurobiological changes, including alterations in white matter microstructure [<xref ref-type="bibr" rid="ref124">124</xref>-<xref ref-type="bibr" rid="ref128">128</xref>].</p><p>Finally, many studies did not clearly report key methodological details, such as the degree of digitalization or level of human support. Although we conducted analyses including and excluding the &#x201C;Not reported&#x201D; category, the lack of such information led to inconsistent findings, preventing definitive conclusions regarding the impact of digitalization on dropout rates. Future studies should standardize reporting of intervention details, including digitalization and human support, to better understand active components and optimize strategies [<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref129">129</xref>]. Another limitation is the high heterogeneity in the meta-analysis (I&#x00B2;&#x003E;90%), which may reduce robustness. Despite sensitivity and moderator analyses, some variability remained unexplained, suggesting pooled effects may not apply equally across interventions, populations, or outcomes. Future research should adopt rigorous methodologies, including detailed reporting, preregistration, data sharing, and large-scale RCTs. Individual participant data meta-analyses can further clarify subgroup effects and sources of heterogeneity, improving generalizability [<xref ref-type="bibr" rid="ref130">130</xref>].</p></sec><sec id="s4-4"><title>Conclusion</title><p>In summary, this meta-analysis systematically examined dropout rates and their predictive factors in digital psychosocial interventions for adult illicit drug users, aiming to provide a comprehensive picture of the research landscape in this field. The results indicate that both short-term and long-term adherence to interventions are characterized by considerable complexity. In the short term, dropout rates were primarily associated with employment status, baseline clinical diagnoses, baseline primary substance use, and intervention frequency. Over longer follow-up periods, marital status, baseline drug use frequency, and recruitment source emerged as key predictors. These findings suggest the need for further investigation into factors that contradict common assumptions or remain insufficiently reported in the literature, as well as greater standardization in the design, measurement, and reporting of randomized controlled trials to improve research quality. Moreover, more attention should be given to tailoring interventions for specific populations, particularly through the design of intervention functions and modules. Continued exploration in these areas will contribute to better supporting patients&#x2019; long-term recovery.</p></sec></sec></body><back><ack><p>This work was funded by the Major Program of the National Social Science Foundation of China, under Grant No. 22&#x0026;ZD187.</p></ack><fn-group><fn fn-type="con"><p>Conceptualization: LJY (lead), LXY (equal)</p><p>Data curation: LJY (lead), LXY (equal), MTN (supporting)</p><p>Formal analysis: LJY (lead), LXY (supporting)</p><p>Funding acquisition: RZH</p><p>Investigation: LJY (lead), LXY (equal)</p><p>Methodology: LJY (lead), LXY (equal)</p><p>Project administration: RZH</p><p>Resources: RZH</p><p>Software: LJY (lead), LXY (equal)</p><p>Supervision: RZH</p><p>Validation: LJY (lead), LXY (equal)</p><p>Visualization: LJY</p><p>Writing &#x2013; original draft: LJY</p><p>Writing &#x2013; review &#x0026; editing: RZH (lead), DXY (supporting), LXY (supporting)</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">CMA 4.0</term><def><p>Comprehensive Meta-Analysis software</p></def></def-item><def-item><term id="abb2">NR</term><def><p>Not reported</p></def></def-item><def-item><term id="abb3">PRISMA</term><def><p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</p></def></def-item><def-item><term id="abb4">ROB 2.0</term><def><p>Cochrane risk of bias tool</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="web"><article-title>World drug report 2024 (united nations publication, 2024)</article-title><source>UNODC</source><access-date>2025-04-16</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html">https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Crescenzo</surname><given-names>F</given-names> </name><name name-style="western"><surname>Ciabattini</surname><given-names>M</given-names> </name><name name-style="western"><surname>D&#x2019;Al&#x00F2;</surname><given-names>GL</given-names> </name><etal/></person-group><article-title>Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: a systematic review and network meta-analysis</article-title><source>PLoS Med</source><year>2018</year><month>12</month><volume>15</volume><issue>12</issue><fpage>e1002715</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002715</pub-id><pub-id pub-id-type="medline">30586362</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rooke</surname><given-names>S</given-names> </name><name name-style="western"><surname>Copeland</surname><given-names>J</given-names> </name><name name-style="western"><surname>Norberg</surname><given-names>M</given-names> </name><name name-style="western"><surname>Hine</surname><given-names>D</given-names> </name><name name-style="western"><surname>McCambridge</surname><given-names>J</given-names> </name></person-group><article-title>Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2013</year><month>02</month><day>15</day><volume>15</volume><issue>2</issue><fpage>e26</fpage><pub-id pub-id-type="doi">10.2196/jmir.2256</pub-id><pub-id pub-id-type="medline">23470329</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gainer</surname><given-names>DM</given-names> </name><name name-style="western"><surname>Wong</surname><given-names>C</given-names> </name><name name-style="western"><surname>Embree</surname><given-names>JA</given-names> </name><name name-style="western"><surname>Sardesh</surname><given-names>N</given-names> </name><name name-style="western"><surname>Amin</surname><given-names>A</given-names> </name><name name-style="western"><surname>Lester</surname><given-names>N</given-names> </name></person-group><article-title>Effects of telehealth on dropout and retention in care among treatment-seeking individuals with substance use disorder: a retrospective cohort study</article-title><source>Subst Use Misuse</source><year>2023</year><volume>58</volume><issue>4</issue><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1080/10826084.2023.2167496</pub-id><pub-id pub-id-type="medline">36710568</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proudfoot</surname><given-names>J</given-names> </name><name name-style="western"><surname>Goldberg</surname><given-names>D</given-names> </name><name name-style="western"><surname>Mann</surname><given-names>A</given-names> </name><name name-style="western"><surname>Everitt</surname><given-names>B</given-names> </name><name name-style="western"><surname>Marks</surname><given-names>I</given-names> </name><name name-style="western"><surname>Gray</surname><given-names>JA</given-names> </name></person-group><article-title>Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice</article-title><source>Psychol Med</source><year>2003</year><month>02</month><volume>33</volume><issue>2</issue><fpage>217</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1017/s0033291702007225</pub-id><pub-id pub-id-type="medline">12622301</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>H</given-names> </name><name name-style="western"><surname>Reynolds</surname><given-names>J</given-names> </name><name name-style="western"><surname>Griffiths</surname><given-names>KM</given-names> </name></person-group><article-title>The use of e-health applications for anxiety and depression in young people: challenges and solutions</article-title><source>Early Interv Psychiatry</source><year>2011</year><month>02</month><volume>5 Suppl 1</volume><issue>58-62</issue><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7893.2010.00242.x</pub-id><pub-id pub-id-type="medline">21208393</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>T</given-names> </name><name name-style="western"><surname>Lucassen</surname><given-names>M</given-names> </name><name name-style="western"><surname>Stasiak</surname><given-names>K</given-names> </name><name name-style="western"><surname>Shepherd</surname><given-names>M</given-names> </name><name name-style="western"><surname>Merry</surname><given-names>S</given-names> </name></person-group><article-title>The impact and utility of computerised therapy for educationally alienated teenagers: the views of adolescents who participated in an alternative education&#x2010;based trial</article-title><source>Clin Psychol (Aust Psychol Soc)</source><year>2016</year><month>07</month><day>1</day><volume>20</volume><issue>2</issue><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1111/cp.12052</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calear</surname><given-names>AL</given-names> </name><name name-style="western"><surname>Christensen</surname><given-names>H</given-names> </name></person-group><article-title>Review of internet-based prevention and treatment programs for anxiety and depression in children and adolescents</article-title><source>Med J Aust</source><year>2010</year><month>06</month><day>7</day><volume>192</volume><issue>S11</issue><fpage>S12</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.5694/j.1326-5377.2010.tb03686.x</pub-id><pub-id pub-id-type="medline">20528700</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Titov</surname><given-names>N</given-names> </name></person-group><article-title>Status of computerized cognitive behavioural therapy for adults</article-title><source>Aust N Z J Psychiatry</source><year>2007</year><month>02</month><volume>41</volume><issue>2</issue><fpage>95</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1080/00048670601109873</pub-id><pub-id pub-id-type="medline">17464688</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blankers</surname><given-names>M</given-names> </name><name name-style="western"><surname>Koeter</surname><given-names>MWJ</given-names> </name><name name-style="western"><surname>Schippers</surname><given-names>GM</given-names> </name></person-group><article-title>Internet therapy versus internet self-help versus no treatment for problematic alcohol use: a randomized controlled trial</article-title><source>J Consult Clin Psychol</source><year>2011</year><month>06</month><volume>79</volume><issue>3</issue><fpage>330</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1037/a0023498</pub-id><pub-id pub-id-type="medline">21534652</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>C&#x00F4;t&#x00E9;</surname><given-names>J</given-names> </name><name name-style="western"><surname>Chicoine</surname><given-names>G</given-names> </name><name name-style="western"><surname>Vinette</surname><given-names>B</given-names> </name><etal/></person-group><article-title>Digital interventions for recreational cannabis use among young adults: systematic review, meta-analysis, and behavior change technique analysis of randomized controlled studies</article-title><source>J Med Internet Res</source><year>2024</year><month>04</month><day>17</day><volume>26</volume><fpage>e55031</fpage><pub-id pub-id-type="doi">10.2196/55031</pub-id><pub-id pub-id-type="medline">38630515</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boumparis</surname><given-names>N</given-names> </name><name name-style="western"><surname>Karyotaki</surname><given-names>E</given-names> </name><name name-style="western"><surname>Schaub</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Cuijpers</surname><given-names>P</given-names> </name><name name-style="western"><surname>Riper</surname><given-names>H</given-names> </name></person-group><article-title>Internet interventions for adult illicit substance users: a meta-analysis</article-title><source>Addiction</source><year>2017</year><month>09</month><volume>112</volume><issue>9</issue><fpage>1521</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1111/add.13819</pub-id><pub-id pub-id-type="medline">28295758</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boumparis</surname><given-names>N</given-names> </name><name name-style="western"><surname>Loheide-Niesmann</surname><given-names>L</given-names> </name><name name-style="western"><surname>Blankers</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Short- and long-term effects of digital prevention and treatment interventions for cannabis use reduction: a systematic review and meta-analysis</article-title><source>Drug Alcohol Depend</source><year>2019</year><month>07</month><day>1</day><volume>200</volume><issue>82-94</issue><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2019.03.016</pub-id><pub-id pub-id-type="medline">31112834</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riper</surname><given-names>H</given-names> </name><name name-style="western"><surname>Hoogendoorn</surname><given-names>A</given-names> </name><name name-style="western"><surname>Cuijpers</surname><given-names>P</given-names> </name><etal/></person-group><article-title>Effectiveness and treatment moderators of internet interventions for adult problem drinking: an individual patient data meta-analysis of 19 randomised controlled trials</article-title><source>PLoS Med</source><year>2018</year><month>12</month><volume>15</volume><issue>12</issue><fpage>e1002714</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002714</pub-id><pub-id pub-id-type="medline">30562347</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eysenbach</surname><given-names>G</given-names> </name></person-group><article-title>The law of attrition</article-title><source>J Med Internet Res</source><year>2005</year><month>03</month><day>31</day><volume>7</volume><issue>1</issue><fpage>e11</fpage><pub-id pub-id-type="doi">10.2196/jmir.7.1.e11</pub-id><pub-id pub-id-type="medline">15829473</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulte</surname><given-names>MHJ</given-names> </name><name name-style="western"><surname>Boumparis</surname><given-names>N</given-names> </name><name name-style="western"><surname>Huizink</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Riper</surname><given-names>H</given-names> </name></person-group><article-title>Technological interventions for the treatment of substance use disorders</article-title><source>Compr Clin Psychol</source><year>2022</year><fpage>264</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-818697-8.00010-8</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaub</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sullivan</surname><given-names>R</given-names> </name><name name-style="western"><surname>Haug</surname><given-names>S</given-names> </name><name name-style="western"><surname>Stark</surname><given-names>L</given-names> </name></person-group><article-title>Web-based cognitive behavioral self-help intervention to reduce cocaine consumption in problematic cocaine users: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2012</year><month>11</month><day>28</day><volume>14</volume><issue>6</issue><fpage>e166</fpage><pub-id pub-id-type="doi">10.2196/jmir.2244</pub-id><pub-id pub-id-type="medline">23192752</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutra</surname><given-names>L</given-names> </name><name name-style="western"><surname>Stathopoulou</surname><given-names>G</given-names> </name><name name-style="western"><surname>Basden</surname><given-names>SL</given-names> </name><name name-style="western"><surname>Leyro</surname><given-names>TM</given-names> </name><name name-style="western"><surname>Powers</surname><given-names>MB</given-names> </name><name name-style="western"><surname>Otto</surname><given-names>MW</given-names> </name></person-group><article-title>A meta-analytic review of psychosocial interventions for substance use disorders</article-title><source>Am J Psychiatry</source><year>2008</year><month>02</month><volume>165</volume><issue>2</issue><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2007.06111851</pub-id><pub-id pub-id-type="medline">18198270</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliva</surname><given-names>EM</given-names> </name><name name-style="western"><surname>Bowe</surname><given-names>T</given-names> </name><name name-style="western"><surname>Harris</surname><given-names>AHS</given-names> </name><name name-style="western"><surname>Trafton</surname><given-names>JA</given-names> </name></person-group><article-title>Datapoints: false starts in psychotherapy for substance use disorders and PTSD in the VHA</article-title><source>Psychiatr Serv</source><year>2013</year><month>08</month><day>1</day><volume>64</volume><issue>8</issue><fpage>722</fpage><pub-id pub-id-type="doi">10.1176/appi.ps.201300145</pub-id><pub-id pub-id-type="medline">23903602</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedden</surname><given-names>SL</given-names> </name><name name-style="western"><surname>Woolson</surname><given-names>RF</given-names> </name><name name-style="western"><surname>Carter</surname><given-names>RE</given-names> </name><name name-style="western"><surname>Palesch</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Upadhyaya</surname><given-names>HP</given-names> </name><name name-style="western"><surname>Malcolm</surname><given-names>RJ</given-names> </name></person-group><article-title>The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials</article-title><source>J Subst Abuse Treat</source><year>2009</year><month>07</month><volume>37</volume><issue>1</issue><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2008.09.011</pub-id><pub-id pub-id-type="medline">19008067</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morina</surname><given-names>N</given-names> </name><name name-style="western"><surname>Wicherts</surname><given-names>JM</given-names> </name><name name-style="western"><surname>Lobbrecht</surname><given-names>J</given-names> </name><name name-style="western"><surname>Priebe</surname><given-names>S</given-names> </name></person-group><article-title>Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long term outcome studies</article-title><source>Clin Psychol Rev</source><year>2014</year><month>04</month><volume>34</volume><issue>3</issue><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2014.03.002</pub-id><pub-id pub-id-type="medline">24681171</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>AA</given-names> </name><name name-style="western"><surname>Kline</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Baier</surname><given-names>AL</given-names> </name><name name-style="western"><surname>Feeny</surname><given-names>NC</given-names> </name></person-group><article-title>Rethinking research on prediction and prevention of psychotherapy dropout: a mechanism-oriented approach</article-title><source>Behav Modif</source><year>2023</year><month>11</month><volume>47</volume><issue>6</issue><fpage>1195</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1177/0145445518792251</pub-id><pub-id pub-id-type="medline">30079755</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perski</surname><given-names>O</given-names> </name><name name-style="western"><surname>Blandford</surname><given-names>A</given-names> </name><name name-style="western"><surname>West</surname><given-names>R</given-names> </name><name name-style="western"><surname>Michie</surname><given-names>S</given-names> </name></person-group><article-title>Conceptualising engagement with digital behaviour change interventions: a systematic review using principles from critical interpretive synthesis</article-title><source>Transl Behav Med</source><year>2017</year><month>06</month><volume>7</volume><issue>2</issue><fpage>254</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/s13142-016-0453-1</pub-id><pub-id pub-id-type="medline">27966189</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sieverink</surname><given-names>F</given-names> </name><name name-style="western"><surname>Kelders</surname><given-names>SM</given-names> </name><name name-style="western"><surname>van Gemert-Pijnen</surname><given-names>JE</given-names> </name></person-group><article-title>Clarifying the concept of adherence to eHealth technology: systematic review on when usage becomes adherence</article-title><source>J Med Internet Res</source><year>2017</year><month>12</month><day>6</day><volume>19</volume><issue>12</issue><fpage>e402</fpage><pub-id pub-id-type="doi">10.2196/jmir.8578</pub-id><pub-id pub-id-type="medline">29212630</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christoff</surname><given-names>A de O</given-names> </name><name name-style="western"><surname>Boerngen-Lacerda</surname><given-names>R</given-names> </name></person-group><article-title>Reducing substance involvement in college students: a three-arm parallel-group randomized controlled trial of a computer-based intervention</article-title><source>Addict Behav</source><year>2015</year><month>06</month><volume>45</volume><issue>164-71</issue><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2015.01.019</pub-id><pub-id pub-id-type="medline">25679364</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Casteel</surname><given-names>D</given-names> </name><name name-style="western"><surname>Shigekawa</surname><given-names>E</given-names> </name><name name-style="western"><surname>Weyrich</surname><given-names>MS</given-names> </name><name name-style="western"><surname>Roby</surname><given-names>DH</given-names> </name><name name-style="western"><surname>McMenamin</surname><given-names>SB</given-names> </name></person-group><article-title>Telemedicine-delivered treatment interventions for substance use disorders: a systematic review</article-title><source>J Subst Abuse Treat</source><year>2019</year><month>06</month><volume>101</volume><issue>38-49</issue><fpage>38</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2019.03.007</pub-id><pub-id pub-id-type="medline">31006553</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mogk</surname><given-names>J</given-names> </name><name name-style="western"><surname>Idu</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Bobb</surname><given-names>JF</given-names> </name><etal/></person-group><article-title>Prescription digital therapeutics for substance use disorder in primary care: mixed methods evaluation of a pilot implementation study</article-title><source>JMIR Form Res</source><year>2024</year><month>09</month><day>2</day><volume>8</volume><fpage>e59088</fpage><pub-id pub-id-type="doi">10.2196/59088</pub-id><pub-id pub-id-type="medline">39222348</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prochaska</surname><given-names>JJ</given-names> </name><name name-style="western"><surname>Vogel</surname><given-names>EA</given-names> </name><name name-style="western"><surname>Chieng</surname><given-names>A</given-names> </name><etal/></person-group><article-title>A therapeutic relational agent for reducing problematic substance use (Woebot): development and usability study</article-title><source>J Med Internet Res</source><year>2021</year><month>03</month><day>23</day><volume>23</volume><issue>3</issue><fpage>e24850</fpage><pub-id pub-id-type="doi">10.2196/24850</pub-id><pub-id pub-id-type="medline">33755028</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Windle</surname><given-names>E</given-names> </name><name name-style="western"><surname>Tee</surname><given-names>H</given-names> </name><name name-style="western"><surname>Sabitova</surname><given-names>A</given-names> </name><name name-style="western"><surname>Jovanovic</surname><given-names>N</given-names> </name><name name-style="western"><surname>Priebe</surname><given-names>S</given-names> </name><name name-style="western"><surname>Carr</surname><given-names>C</given-names> </name></person-group><article-title>Association of patient treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions: a systematic review and meta-analysis</article-title><source>JAMA Psychiatr</source><year>2020</year><month>03</month><day>1</day><volume>77</volume><issue>3</issue><fpage>294</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.3750</pub-id><pub-id pub-id-type="medline">31799994</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Chandler</surname><given-names>J</given-names> </name><name name-style="western"><surname>Cumpston</surname><given-names>M</given-names> </name><name name-style="western"><surname>Li</surname><given-names>T</given-names> </name><name name-style="western"><surname>Page</surname><given-names>MJ</given-names> </name></person-group><source>Cochrane Handbook for Systematic Reviews of Interventions Version 65 (Updated August 2024)</source><year>2024</year><access-date>2024-04-10</access-date><volume>6</volume><publisher-name>Cochrane</publisher-name><fpage>5</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.cochrane.org/handbook">www.cochrane.org/handbook</ext-link></comment></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>Moher</surname><given-names>D</given-names> </name><name name-style="western"><surname>Bossuyt</surname><given-names>PM</given-names> </name><etal/></person-group><article-title>PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><month>03</month><day>29</day><volume>372</volume><fpage>n160</fpage><pub-id pub-id-type="doi">10.1136/bmj.n160</pub-id><pub-id pub-id-type="medline">33781993</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siqueland</surname><given-names>L</given-names> </name><name name-style="western"><surname>Crits-Christoph</surname><given-names>P</given-names> </name><name name-style="western"><surname>Frank</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Predictors of dropout from psychosocial treatment of cocaine dependence</article-title><source>Drug Alcohol Depend</source><year>1998</year><month>09</month><day>1</day><volume>52</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/s0376-8716(98)00039-8</pub-id><pub-id pub-id-type="medline">9788001</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bickel</surname><given-names>WK</given-names> </name><name name-style="western"><surname>Marsch</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Buchhalter</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Badger</surname><given-names>GJ</given-names> </name></person-group><article-title>Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial</article-title><source>Exp Clin Psychopharmacol</source><year>2008</year><month>04</month><volume>16</volume><issue>2</issue><fpage>132</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1037/1064-1297.16.2.132</pub-id><pub-id pub-id-type="medline">18489017</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markowitz</surname><given-names>JC</given-names> </name></person-group><article-title>Prevention of relapse following cognitive therapy vs medications in moderate to severe depression</article-title><source>Yearb Psychiatry Appl Ment Health</source><year>2006</year><month>01</month><volume>2006</volume><fpage>65</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/S0084-3970(08)70065-3</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcovitz</surname><given-names>DE</given-names> </name><name name-style="western"><surname>McHugh</surname><given-names>RK</given-names> </name><name name-style="western"><surname>Volpe</surname><given-names>J</given-names> </name><name name-style="western"><surname>Votaw</surname><given-names>V</given-names> </name><name name-style="western"><surname>Connery</surname><given-names>HS</given-names> </name></person-group><article-title>Predictors of early dropout in outpatient buprenorphine/naloxone treatment</article-title><source>Am J Addict</source><year>2016</year><month>09</month><volume>25</volume><issue>6</issue><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1111/ajad.12414</pub-id><pub-id pub-id-type="medline">27442456</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKellar</surname><given-names>J</given-names> </name><name name-style="western"><surname>Kelly</surname><given-names>J</given-names> </name><name name-style="western"><surname>Harris</surname><given-names>A</given-names> </name><name name-style="western"><surname>Moos</surname><given-names>R</given-names> </name></person-group><article-title>Pretreatment and during treatment risk factors for dropout among patients with substance use disorders</article-title><source>Addict Behav</source><year>2006</year><month>03</month><volume>31</volume><issue>3</issue><fpage>450</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2005.05.024</pub-id><pub-id pub-id-type="medline">15979244</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lappan</surname><given-names>SN</given-names> </name><name name-style="western"><surname>Brown</surname><given-names>AW</given-names> </name><name name-style="western"><surname>Hendricks</surname><given-names>PS</given-names> </name></person-group><article-title>Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis</article-title><source>Addiction</source><year>2020</year><month>02</month><volume>115</volume><issue>2</issue><fpage>201</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1111/add.14793</pub-id><pub-id pub-id-type="medline">31454123</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>J</given-names> </name><name name-style="western"><surname>Werbart</surname><given-names>A</given-names> </name></person-group><article-title>Therapist and relationship factors influencing dropout from individual psychotherapy: a literature review</article-title><source>Psychother Res</source><year>2013</year><volume>23</volume><issue>4</issue><fpage>394</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1080/10503307.2013.775528</pub-id><pub-id pub-id-type="medline">23461273</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Haan</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Boon</surname><given-names>AE</given-names> </name><name name-style="western"><surname>de Jong</surname><given-names>J</given-names> </name><name name-style="western"><surname>Hoeve</surname><given-names>M</given-names> </name><name name-style="western"><surname>Vermeiren</surname><given-names>R</given-names> </name></person-group><article-title>A meta-analytic review on treatment dropout in child and adolescent outpatient mental health care</article-title><source>Clin Psychol Rev</source><year>2013</year><month>07</month><volume>33</volume><issue>5</issue><fpage>698</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2013.04.005</pub-id><pub-id pub-id-type="medline">23742782</pub-id></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names> </name><name name-style="western"><surname>Michaelides</surname><given-names>M</given-names> </name><name name-style="western"><surname>Baler</surname><given-names>R</given-names> </name></person-group><article-title>The neuroscience of drug reward and addiction</article-title><source>Physiol Rev</source><year>2019</year><month>10</month><day>1</day><volume>99</volume><issue>4</issue><fpage>2115</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.1152/physrev.00014.2018</pub-id><pub-id pub-id-type="medline">31507244</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kessler</surname><given-names>RC</given-names> </name><name name-style="western"><surname>Berglund</surname><given-names>P</given-names> </name><name name-style="western"><surname>Demler</surname><given-names>O</given-names> </name><etal/></person-group><article-title>The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)</article-title><source>JAMA</source><year>2003</year><month>06</month><day>18</day><volume>289</volume><issue>23</issue><fpage>3095</fpage><lpage>3105</lpage><pub-id pub-id-type="doi">10.1001/jama.289.23.3095</pub-id><pub-id pub-id-type="medline">12813115</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>S</given-names> </name><name name-style="western"><surname>Moore</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Crane</surname><given-names>DR</given-names> </name><name name-style="western"><surname>Payne</surname><given-names>SH</given-names> </name></person-group><article-title>Psychotherapy dropouts: differences by modality, license, and DSM-IV diagnosis</article-title><source>J Marital Fam Ther</source><year>2011</year><month>07</month><volume>37</volume><issue>3</issue><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1111/j.1752-0606.2010.00204.x</pub-id><pub-id pub-id-type="medline">21745235</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Derubeis</surname><given-names>RJ</given-names> </name><name name-style="western"><surname>Gelfand</surname><given-names>LA</given-names> </name><name name-style="western"><surname>German</surname><given-names>RE</given-names> </name><name name-style="western"><surname>Fournier</surname><given-names>JC</given-names> </name><name name-style="western"><surname>Forand</surname><given-names>NR</given-names> </name></person-group><article-title>Understanding processes of change: how some patients reveal more than others-and some groups of therapists less-about what matters in psychotherapy</article-title><source>Psychother Res</source><year>2014</year><volume>24</volume><issue>3</issue><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1080/10503307.2013.838654</pub-id><pub-id pub-id-type="medline">24219275</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magura</surname><given-names>S</given-names> </name><name name-style="western"><surname>Rosenblum</surname><given-names>A</given-names> </name><name name-style="western"><surname>Fong</surname><given-names>C</given-names> </name></person-group><article-title>Factors associated with medication adherence among psychiatric outpatients at substance abuse risk</article-title><source>Open Addict J</source><year>2011</year><month>11</month><day>11</day><volume>4</volume><issue>58-64</issue><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.2174/1874941001104010058</pub-id><pub-id pub-id-type="medline">23264842</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sterne</surname><given-names>JAC</given-names> </name><name name-style="western"><surname>Savovi&#x0107;</surname><given-names>J</given-names> </name><name name-style="western"><surname>Page</surname><given-names>MJ</given-names> </name><etal/></person-group><article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title><source>BMJ</source><year>2019</year><month>08</month><day>28</day><volume>366</volume><fpage>l4898</fpage><pub-id pub-id-type="doi">10.1136/bmj.l4898</pub-id><pub-id pub-id-type="medline">31462531</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Borenstein</surname><given-names>M</given-names> </name><name name-style="western"><surname>Hedges</surname><given-names>LE</given-names> </name><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name><name name-style="western"><surname>Rothstein</surname><given-names>HR</given-names> </name></person-group><source>Comprehensive Meta-Analysis Version 4 Biostat, Inc</source><year>2022</year><access-date>2024-11-05</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.Meta-Analysis.com">https://www.Meta-Analysis.com</ext-link></comment></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>TH</given-names> </name><name name-style="western"><surname>Migliavaca</surname><given-names>CB</given-names> </name><name name-style="western"><surname>Stein</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence</article-title><source>BMC Med Res Methodol</source><year>2021</year><month>09</month><day>20</day><volume>21</volume><issue>1</issue><fpage>189</fpage><pub-id pub-id-type="doi">10.1186/s12874-021-01381-z</pub-id><pub-id pub-id-type="medline">34544368</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names> </name><name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names> </name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names> </name></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><month>09</month><day>6</day><volume>327</volume><issue>7414</issue><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="medline">12958120</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borenstein</surname><given-names>M</given-names> </name></person-group><article-title>Avoiding common mistakes in meta-analysis: understanding the distinct roles of Q, I-squared, tau-squared, and the prediction interval in reporting heterogeneity</article-title><source>Res Synth Methods</source><year>2024</year><month>03</month><volume>15</volume><issue>2</issue><fpage>354</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1002/jrsm.1678</pub-id><pub-id pub-id-type="medline">37940120</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borenstein</surname><given-names>M</given-names> </name></person-group><article-title>Research note: In a meta-analysis, the I<sup>2</sup> index does not tell us how much the effect size varies across studies</article-title><source>J Physiother</source><year>2020</year><month>04</month><volume>66</volume><issue>2</issue><fpage>135</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.jphys.2020.02.011</pub-id><pub-id pub-id-type="medline">32307309</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borenstein</surname><given-names>M</given-names> </name><name name-style="western"><surname>Hedges</surname><given-names>LV</given-names> </name><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name><name name-style="western"><surname>Rothstein</surname><given-names>HR</given-names> </name></person-group><article-title>A basic introduction to fixed-effect and random-effects models for meta-analysis</article-title><source>Res Synth Methods</source><year>2010</year><month>04</month><volume>1</volume><issue>2</issue><fpage>97</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/jrsm.12</pub-id><pub-id pub-id-type="medline">26061376</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>IntHout</surname><given-names>J</given-names> </name><name name-style="western"><surname>Ioannidis</surname><given-names>JPA</given-names> </name><name name-style="western"><surname>Rovers</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Goeman</surname><given-names>JJ</given-names> </name></person-group><article-title>Plea for routinely presenting prediction intervals in meta-analysis</article-title><source>BMJ Open</source><year>2016</year><month>07</month><day>12</day><volume>6</volume><issue>7</issue><fpage>e010247</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-010247</pub-id><pub-id pub-id-type="medline">27406637</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolakopoulou</surname><given-names>A</given-names> </name><name name-style="western"><surname>Mavridis</surname><given-names>D</given-names> </name><name name-style="western"><surname>Salanti</surname><given-names>G</given-names> </name></person-group><article-title>Demystifying fixed and random effects meta-analysis</article-title><source>Evid Based Mental Health</source><year>2014</year><month>05</month><volume>17</volume><issue>2</issue><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1136/eb-2014-101795</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>A</given-names> </name><name name-style="western"><surname>Lee</surname><given-names>P</given-names> </name></person-group><article-title>Publication bias in meta-analysis: its causes and consequences</article-title><source>J Clin Epidemiol</source><year>2000</year><month>02</month><volume>53</volume><issue>2</issue><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/s0895-4356(99)00161-4</pub-id><pub-id pub-id-type="medline">10729693</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aharonovich</surname><given-names>E</given-names> </name><name name-style="western"><surname>Greenstein</surname><given-names>E</given-names> </name><name name-style="western"><surname>O&#x2019;Leary</surname><given-names>A</given-names> </name><name name-style="western"><surname>Johnston</surname><given-names>B</given-names> </name><name name-style="western"><surname>Seol</surname><given-names>SG</given-names> </name><name name-style="western"><surname>Hasin</surname><given-names>DS</given-names> </name></person-group><article-title>HealthCall: technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study</article-title><source>AIDS Care</source><year>2012</year><volume>24</volume><issue>12</issue><fpage>1461</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1080/09540121.2012.663882</pub-id><pub-id pub-id-type="medline">22428809</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aharonovich</surname><given-names>E</given-names> </name><name name-style="western"><surname>Sarvet</surname><given-names>A</given-names> </name><name name-style="western"><surname>Stohl</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Reducing non-injection drug use in HIV primary care: a randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement</article-title><source>J Subst Abuse Treat</source><year>2017</year><month>03</month><volume>74</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2016.12.009</pub-id><pub-id pub-id-type="medline">28132704</pub-id></nlm-citation></ref><ref id="ref57"><label>57</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aharonovich</surname><given-names>E</given-names> </name><name name-style="western"><surname>Stohl</surname><given-names>M</given-names> </name><name name-style="western"><surname>Cannizzaro</surname><given-names>D</given-names> </name><name name-style="western"><surname>Hasin</surname><given-names>D</given-names> </name></person-group><article-title>HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial</article-title><source>J Subst Abuse Treat</source><year>2017</year><month>12</month><volume>83</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2017.09.013</pub-id><pub-id pub-id-type="medline">29129192</pub-id></nlm-citation></ref><ref id="ref58"><label>58</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumgartner</surname><given-names>C</given-names> </name><name name-style="western"><surname>Schaub</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Wenger</surname><given-names>A</given-names> </name><etal/></person-group><article-title>CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial</article-title><source>J Med Internet Res</source><year>2021</year><month>04</month><day>30</day><volume>23</volume><issue>4</issue><fpage>e27463</fpage><pub-id pub-id-type="doi">10.2196/27463</pub-id><pub-id pub-id-type="medline">33929333</pub-id></nlm-citation></ref><ref id="ref59"><label>59</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blow</surname><given-names>FC</given-names> </name><name name-style="western"><surname>Walton</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Bohnert</surname><given-names>ASB</given-names> </name><etal/></person-group><article-title>A randomized controlled trial of brief interventions to reduce drug use among adults in a low-income urban emergency department: the HealthiER You study</article-title><source>Addiction</source><year>2017</year><month>08</month><volume>112</volume><issue>8</issue><fpage>1395</fpage><lpage>1405</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://doi.wiley.com/10.1111/add.v112.8">http://doi.wiley.com/10.1111/add.v112.8</ext-link></comment><pub-id pub-id-type="doi">10.1111/add.13773</pub-id><pub-id pub-id-type="medline">28127808</pub-id></nlm-citation></ref><ref id="ref60"><label>60</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonar</surname><given-names>EE</given-names> </name><name name-style="western"><surname>Goldstick</surname><given-names>JE</given-names> </name><name name-style="western"><surname>Chapman</surname><given-names>L</given-names> </name><etal/></person-group><article-title>A social media intervention for cannabis use among emerging adults: Randomized controlled trial</article-title><source>Drug Alcohol Depend</source><year>2022</year><month>03</month><day>1</day><volume>232</volume><fpage>109345</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2022.109345</pub-id><pub-id pub-id-type="medline">35144238</pub-id></nlm-citation></ref><ref id="ref61"><label>61</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonar</surname><given-names>EE</given-names> </name><name name-style="western"><surname>Goldstick</surname><given-names>JE</given-names> </name><name name-style="western"><surname>Tan</surname><given-names>CY</given-names> </name><etal/></person-group><article-title>A remote brief intervention plus social media messaging for cannabis use among emerging adults: A pilot randomized controlled trial in emergency department patients</article-title><source>Addict Behav</source><year>2023</year><month>12</month><volume>147</volume><fpage>107829</fpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2023.107829</pub-id><pub-id pub-id-type="medline">37598642</pub-id></nlm-citation></ref><ref id="ref62"><label>62</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Ryder</surname><given-names>D</given-names> </name><name name-style="western"><surname>Carise</surname><given-names>D</given-names> </name><name name-style="western"><surname>Kirby</surname><given-names>KC</given-names> </name></person-group><article-title>Feasibility and effectiveness of computer-based therapy in community treatment</article-title><source>J Subst Abuse Treat</source><year>2010</year><month>10</month><volume>39</volume><issue>3</issue><fpage>227</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2010.06.003</pub-id><pub-id pub-id-type="medline">20667682</pub-id></nlm-citation></ref><ref id="ref63"><label>63</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buckner</surname><given-names>JD</given-names> </name><name name-style="western"><surname>Zvolensky</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>Lewis</surname><given-names>EM</given-names> </name></person-group><article-title>On-line personalized feedback intervention for negative affect and cannabis: A pilot randomized controlled trial</article-title><source>Exp Clin Psychopharmacol</source><year>2020</year><month>04</month><volume>28</volume><issue>2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1037/pha0000304</pub-id><pub-id pub-id-type="medline">31204824</pub-id></nlm-citation></ref><ref id="ref64"><label>64</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budney</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Fearer</surname><given-names>S</given-names> </name><name name-style="western"><surname>Walker</surname><given-names>DD</given-names> </name><etal/></person-group><article-title>An initial trial of a computerized behavioral intervention for cannabis use disorder</article-title><source>Drug Alcohol Depend</source><year>2011</year><month>05</month><day>1</day><volume>115</volume><issue>1-2</issue><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2010.10.014</pub-id><pub-id pub-id-type="medline">21131143</pub-id></nlm-citation></ref><ref id="ref65"><label>65</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budney</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Stanger</surname><given-names>C</given-names> </name><name name-style="western"><surname>Tilford</surname><given-names>JM</given-names> </name><etal/></person-group><article-title>Computer-assisted behavioral therapy and contingency management for cannabis use disorder</article-title><source>Psychol Addict Behav</source><year>2015</year><month>09</month><volume>29</volume><issue>3</issue><fpage>501</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1037/adb0000078</pub-id><pub-id pub-id-type="medline">25938629</pub-id></nlm-citation></ref><ref id="ref66"><label>66</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>ANC</given-names> </name><name name-style="western"><surname>Nunes</surname><given-names>EV</given-names> </name><name name-style="western"><surname>Matthews</surname><given-names>AG</given-names> </name><etal/></person-group><article-title>Internet-delivered treatment for substance abuse: a multisite randomized controlled trial</article-title><source>Am J Psychiatry</source><year>2014</year><month>06</month><volume>171</volume><issue>6</issue><fpage>683</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2014.13081055</pub-id><pub-id pub-id-type="medline">24700332</pub-id></nlm-citation></ref><ref id="ref67"><label>67</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>KM</given-names> </name><name name-style="western"><surname>Kiluk</surname><given-names>BD</given-names> </name><name name-style="western"><surname>Nich</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone</article-title><source>Am J Psychiatry</source><year>2014</year><month>04</month><volume>171</volume><issue>4</issue><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13070987</pub-id><pub-id pub-id-type="medline">24577287</pub-id></nlm-citation></ref><ref id="ref68"><label>68</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chopra</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Landes</surname><given-names>RD</given-names> </name><name name-style="western"><surname>Gatchalian</surname><given-names>KM</given-names> </name><etal/></person-group><article-title>Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine</article-title><source>Exp Clin Psychopharmacol</source><year>2009</year><month>08</month><volume>17</volume><issue>4</issue><fpage>226</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1037/a0016597</pub-id><pub-id pub-id-type="medline">19653788</pub-id></nlm-citation></ref><ref id="ref69"><label>69</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christensen</surname><given-names>DR</given-names> </name><name name-style="western"><surname>Landes</surname><given-names>RD</given-names> </name><name name-style="western"><surname>Jackson</surname><given-names>L</given-names> </name><etal/></person-group><article-title>Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence</article-title><source>J Consult Clin Psychol</source><year>2014</year><month>12</month><volume>82</volume><issue>6</issue><fpage>964</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1037/a0037496</pub-id><pub-id pub-id-type="medline">25090043</pub-id></nlm-citation></ref><ref id="ref70"><label>70</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chun-Hung</surname><given-names>L</given-names> </name><name name-style="western"><surname>Guan-Hsiung</surname><given-names>L</given-names> </name><name name-style="western"><surname>Wu-Chuan</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Yu-Hsin</surname><given-names>L</given-names> </name></person-group><article-title>Chatbot-assisted therapy for patients with methamphetamine use disorder: a preliminary randomized controlled trial</article-title><source>Front Psychiatry</source><year>2023</year><volume>14</volume><fpage>1159399</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2023.1159399</pub-id><pub-id pub-id-type="medline">37484677</pub-id></nlm-citation></ref><ref id="ref71"><label>71</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conner</surname><given-names>BT</given-names> </name><name name-style="western"><surname>Thompson</surname><given-names>K</given-names> </name><name name-style="western"><surname>Prince</surname><given-names>MA</given-names> </name><etal/></person-group><article-title>Results of a randomized controlled trial of the cannabis eCHECKUP TO GO personalized normative feedback intervention on reducing cannabis use, cannabis consequences, and descriptive norms</article-title><source>J Subst Use Addict Treat</source><year>2024</year><month>04</month><volume>159</volume><fpage>209267</fpage><pub-id pub-id-type="doi">10.1016/j.josat.2023.209267</pub-id><pub-id pub-id-type="medline">38103837</pub-id></nlm-citation></ref><ref id="ref72"><label>72</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coronado-Montoya</surname><given-names>S</given-names> </name><name name-style="western"><surname>Abdel-Baki</surname><given-names>A</given-names> </name><name name-style="western"><surname>Bodson-Clermont</surname><given-names>P</given-names> </name><etal/></person-group><article-title>A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis</article-title><source>Psychiatry Res</source><year>2025</year><month>08</month><volume>350</volume><fpage>116553</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2025.116553</pub-id><pub-id pub-id-type="medline">40450961</pub-id></nlm-citation></ref><ref id="ref73"><label>73</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunn</surname><given-names>KE</given-names> </name><name name-style="western"><surname>Yepez-Laubach</surname><given-names>C</given-names> </name><name name-style="western"><surname>Nuzzo</surname><given-names>PA</given-names> </name><etal/></person-group><article-title>Randomized controlled trial of a computerized opioid overdose education intervention</article-title><source>Drug Alcohol Depend</source><year>2017</year><month>04</month><day>1</day><volume>173 Suppl 1</volume><fpage>S39</fpage><lpage>S47</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2016.12.003</pub-id><pub-id pub-id-type="medline">28363318</pub-id></nlm-citation></ref><ref id="ref74"><label>74</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>JC</given-names> </name><name name-style="western"><surname>Carey</surname><given-names>KB</given-names> </name><name name-style="western"><surname>Vanable</surname><given-names>PA</given-names> </name></person-group><article-title>A preliminary evaluation of a web-based intervention for college marijuana use</article-title><source>Psychol Addict Behav</source><year>2014</year><month>03</month><volume>28</volume><issue>1</issue><fpage>288</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1037/a0034995</pub-id><pub-id pub-id-type="medline">24731118</pub-id></nlm-citation></ref><ref id="ref75"><label>75</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glasner</surname><given-names>S</given-names> </name><name name-style="western"><surname>Patrick</surname><given-names>K</given-names> </name><name name-style="western"><surname>Ybarra</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders</article-title><source>Drug Alcohol Depend</source><year>2022</year><month>02</month><day>1</day><volume>231</volume><fpage>109229</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.109229</pub-id><pub-id pub-id-type="medline">34979421</pub-id></nlm-citation></ref><ref id="ref76"><label>76</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gryczynski</surname><given-names>J</given-names> </name><name name-style="western"><surname>Mitchell</surname><given-names>SG</given-names> </name><name name-style="western"><surname>Gonzales</surname><given-names>A</given-names> </name><etal/></person-group><article-title>A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months</article-title><source>J Subst Abuse Treat</source><year>2015</year><month>03</month><volume>50</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2014.09.002</pub-id><pub-id pub-id-type="medline">25282578</pub-id></nlm-citation></ref><ref id="ref77"><label>77</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gryczynski</surname><given-names>J</given-names> </name><name name-style="western"><surname>O&#x2019;Grady</surname><given-names>KE</given-names> </name><name name-style="western"><surname>Mitchell</surname><given-names>SG</given-names> </name><name name-style="western"><surname>Ondersma</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names> </name></person-group><article-title>Immediate versus delayed computerized brief intervention for illicit drug misuse</article-title><source>J Addict Med</source><year>2016</year><volume>10</volume><issue>5</issue><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1097/ADM.0000000000000248</pub-id><pub-id pub-id-type="medline">27504925</pub-id></nlm-citation></ref><ref id="ref78"><label>78</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafson</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Landucci</surname><given-names>G</given-names> </name><name name-style="western"><surname>Vjorn</surname><given-names>OJ</given-names> </name><etal/></person-group><article-title>Effects of bundling medication for opioid use disorder with an mhealth intervention targeting addiction: a randomized clinical trial</article-title><source>Am J Psychiatry</source><year>2024</year><month>02</month><day>1</day><volume>181</volume><issue>2</issue><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.20230055</pub-id><pub-id pub-id-type="medline">37789744</pub-id></nlm-citation></ref><ref id="ref79"><label>79</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingersoll</surname><given-names>KS</given-names> </name><name name-style="western"><surname>Farrell-Carnahan</surname><given-names>L</given-names> </name><name name-style="western"><surname>Cohen-Filipic</surname><given-names>J</given-names> </name><etal/></person-group><article-title>A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users</article-title><source>Drug Alcohol Depend</source><year>2011</year><month>07</month><day>1</day><volume>116</volume><issue>1-3</issue><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2010.12.016</pub-id><pub-id pub-id-type="medline">21306837</pub-id></nlm-citation></ref><ref id="ref80"><label>80</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maricich</surname><given-names>YA</given-names> </name><name name-style="western"><surname>Bickel</surname><given-names>WK</given-names> </name><name name-style="western"><surname>Marsch</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Gatchalian</surname><given-names>K</given-names> </name><name name-style="western"><surname>Botbyl</surname><given-names>J</given-names> </name><name name-style="western"><surname>Luderer</surname><given-names>HF</given-names> </name></person-group><article-title>Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder</article-title><source>Curr Med Res Opin</source><year>2021</year><month>02</month><volume>37</volume><issue>2</issue><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1080/03007995.2020.1846022</pub-id><pub-id pub-id-type="medline">33140994</pub-id></nlm-citation></ref><ref id="ref81"><label>81</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsch</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Guarino</surname><given-names>H</given-names> </name><name name-style="western"><surname>Acosta</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment</article-title><source>J Subst Abuse Treat</source><year>2014</year><month>01</month><volume>46</volume><issue>1</issue><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2013.08.012</pub-id><pub-id pub-id-type="medline">24060350</pub-id></nlm-citation></ref><ref id="ref82"><label>82</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>BA</given-names> </name><name name-style="western"><surname>Buono</surname><given-names>FD</given-names> </name><name name-style="western"><surname>Lloyd</surname><given-names>DP</given-names> </name><name name-style="western"><surname>Printz</surname><given-names>DMB</given-names> </name><name name-style="western"><surname>Fiellin</surname><given-names>DA</given-names> </name><name name-style="western"><surname>Barry</surname><given-names>DT</given-names> </name></person-group><article-title>A randomized clinical trial of the recovery line among methadone treatment patients with ongoing illicit drug use</article-title><source>J Subst Abuse Treat</source><year>2019</year><month>02</month><volume>97</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2018.11.011</pub-id><pub-id pub-id-type="medline">30577901</pub-id></nlm-citation></ref><ref id="ref83"><label>83</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olthof</surname><given-names>MIA</given-names> </name><name name-style="western"><surname>Goudriaan</surname><given-names>AE</given-names> </name><name name-style="western"><surname>van Laar</surname><given-names>MW</given-names> </name><name name-style="western"><surname>Blankers</surname><given-names>M</given-names> </name></person-group><article-title>A guided digital intervention to reduce cannabis use: The ICan randomized controlled trial</article-title><source>Addiction</source><year>2023</year><month>09</month><volume>118</volume><issue>9</issue><fpage>1775</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1111/add.16217</pub-id><pub-id pub-id-type="medline">37128762</pub-id></nlm-citation></ref><ref id="ref84"><label>84</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ondersma</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Svikis</surname><given-names>DS</given-names> </name><name name-style="western"><surname>Schuster</surname><given-names>CR</given-names> </name></person-group><article-title>Computer-based brief intervention</article-title><source>Am J Prev Med</source><year>2007</year><month>03</month><volume>32</volume><issue>3</issue><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2006.11.003</pub-id></nlm-citation></ref><ref id="ref85"><label>85</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ondersma</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Svikis</surname><given-names>DS</given-names> </name><name name-style="western"><surname>Thacker</surname><given-names>LR</given-names> </name><name name-style="western"><surname>Beatty</surname><given-names>JR</given-names> </name><name name-style="western"><surname>Lockhart</surname><given-names>N</given-names> </name></person-group><article-title>Computer-delivered screening and brief intervention (e-SBI) for postpartum drug use: a randomized trial</article-title><source>J Subst Abuse Treat</source><year>2014</year><month>01</month><volume>46</volume><issue>1</issue><fpage>52</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.jsat.2013.07.013</pub-id><pub-id pub-id-type="medline">24051077</pub-id></nlm-citation></ref><ref id="ref86"><label>86</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaub</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Castro</surname><given-names>RP</given-names> </name><name name-style="western"><surname>Wenger</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Web-based self-help with and without chat counseling to reduce cocaine use in cocaine misusers: results of a three-arm randomized controlled trial</article-title><source>Internet Interv</source><year>2019</year><month>09</month><volume>17</volume><issue>100251</issue><fpage>100251</fpage><pub-id pub-id-type="doi">10.1016/j.invent.2019.100251</pub-id><pub-id pub-id-type="medline">31193584</pub-id></nlm-citation></ref><ref id="ref87"><label>87</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaub</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Wenger</surname><given-names>A</given-names> </name><name name-style="western"><surname>Berg</surname><given-names>O</given-names> </name><etal/></person-group><article-title>A web-based self-help intervention with and without chat counseling to reduce cannabis use in problematic cannabis users: three-arm randomized controlled trial</article-title><source>J Med Internet Res</source><year>2015</year><month>10</month><day>13</day><volume>17</volume><issue>10</issue><fpage>e232</fpage><pub-id pub-id-type="doi">10.2196/jmir.4860</pub-id><pub-id pub-id-type="medline">26462848</pub-id></nlm-citation></ref><ref id="ref88"><label>88</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>RP</given-names> </name><name name-style="western"><surname>Gryczynski</surname><given-names>J</given-names> </name><name name-style="western"><surname>Mitchell</surname><given-names>SG</given-names> </name><etal/></person-group><article-title>Computerized versus in-person brief intervention for drug misuse: a randomized clinical trial</article-title><source>Addiction</source><year>2014</year><month>07</month><volume>109</volume><issue>7</issue><fpage>1091</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1111/add.12502</pub-id><pub-id pub-id-type="medline">24520906</pub-id></nlm-citation></ref><ref id="ref89"><label>89</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>JM</given-names> </name><name name-style="western"><surname>Henry</surname><given-names>SP</given-names> </name><name name-style="western"><surname>Dwy</surname><given-names>SL</given-names> </name><name name-style="western"><surname>Orazietti</surname><given-names>SA</given-names> </name><name name-style="western"><surname>Carroll</surname><given-names>KM</given-names> </name></person-group><article-title>Randomized pilot trial of web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance</article-title><source>Subst Abuse</source><year>2019</year><month>04</month><volume>40</volume><issue>2</issue><fpage>132</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1080/08897077.2019.1569192</pub-id></nlm-citation></ref><ref id="ref90"><label>90</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinadinovic</surname><given-names>K</given-names> </name><name name-style="western"><surname>Johansson</surname><given-names>M</given-names> </name><name name-style="western"><surname>Johansson</surname><given-names>AS</given-names> </name><name name-style="western"><surname>Lundqvist</surname><given-names>T</given-names> </name><name name-style="western"><surname>Lindner</surname><given-names>P</given-names> </name><name name-style="western"><surname>Hermansson</surname><given-names>U</given-names> </name></person-group><article-title>Guided web-based treatment program for reducing cannabis use: a randomized controlled trial</article-title><source>Addict Sci Clin Pract</source><year>2020</year><month>02</month><day>18</day><volume>15</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/s13722-020-00185-8</pub-id><pub-id pub-id-type="medline">32070417</pub-id></nlm-citation></ref><ref id="ref91"><label>91</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tait</surname><given-names>RJ</given-names> </name><name name-style="western"><surname>McKetin</surname><given-names>R</given-names> </name><name name-style="western"><surname>Kay-Lambkin</surname><given-names>F</given-names> </name><etal/></person-group><article-title>Six-month outcomes of a web-based intervention for users of amphetamine-type stimulants: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2015</year><month>04</month><day>29</day><volume>17</volume><issue>4</issue><fpage>e105</fpage><pub-id pub-id-type="doi">10.2196/jmir.3778</pub-id><pub-id pub-id-type="medline">25925801</pub-id></nlm-citation></ref><ref id="ref92"><label>92</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tossmann</surname><given-names>D</given-names> </name><name name-style="western"><surname>Jonas</surname><given-names>B</given-names> </name><name name-style="western"><surname>Tensil</surname><given-names>MD</given-names> </name><name name-style="western"><surname>Lang</surname><given-names>P</given-names> </name><name name-style="western"><surname>Str&#x00FC;ber</surname><given-names>E</given-names> </name></person-group><article-title>A controlled trial of an internet-based intervention program for cannabis users</article-title><source>Cyberpsychol Behav Soc Netw</source><year>2011</year><month>11</month><volume>14</volume><issue>11</issue><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1089/cyber.2010.0506</pub-id><pub-id pub-id-type="medline">21651419</pub-id></nlm-citation></ref><ref id="ref93"><label>93</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walukevich-Dienst</surname><given-names>K</given-names> </name><name name-style="western"><surname>Neighbors</surname><given-names>C</given-names> </name><name name-style="western"><surname>Buckner</surname><given-names>JD</given-names> </name></person-group><article-title>Online personalized feedback intervention for cannabis-using college students reduces cannabis-related problems among women</article-title><source>Addict Behav</source><year>2019</year><month>11</month><volume>98</volume><fpage>106040</fpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2019.106040</pub-id><pub-id pub-id-type="medline">31302314</pub-id></nlm-citation></ref><ref id="ref94"><label>94</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X</given-names> </name><name name-style="western"><surname>Chen</surname><given-names>S</given-names> </name><name name-style="western"><surname>Chen</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Feasibility and preliminary efficacy of a community-based addiction rehabilitation electronic system in substance use disorder: pilot randomized controlled trial</article-title><source>JMIR Mhealth Uhealth</source><year>2021</year><month>04</month><day>16</day><volume>9</volume><issue>4</issue><fpage>e21087</fpage><pub-id pub-id-type="doi">10.2196/21087</pub-id><pub-id pub-id-type="medline">33861211</pub-id></nlm-citation></ref><ref id="ref95"><label>95</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouchard</surname><given-names>M</given-names> </name><name name-style="western"><surname>Lecomte</surname><given-names>T</given-names> </name><name name-style="western"><surname>Cloutier</surname><given-names>B</given-names> </name><name name-style="western"><surname>Herrera-Roberge</surname><given-names>J</given-names> </name><name name-style="western"><surname>Potvin</surname><given-names>S</given-names> </name></person-group><article-title>Dropout rates in psychosocial interventions for people with both severe mental illness and substance misuse: a systematic review and meta-analysis</article-title><source>Front Psychiatry</source><year>2022</year><volume>13</volume><issue>842329</issue><fpage>842329</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2022.842329</pub-id><pub-id pub-id-type="medline">35633799</pub-id></nlm-citation></ref><ref id="ref96"><label>96</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shams</surname><given-names>F</given-names> </name><name name-style="western"><surname>Tai</surname><given-names>AMY</given-names> </name><name name-style="western"><surname>Kim</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Adherence to e-health interventions for substance use and the factors influencing it: systematic review, meta-analysis, and meta-regression</article-title><source>Digit Health</source><year>2023</year><volume>9</volume><fpage>20552076231203876</fpage><pub-id pub-id-type="doi">10.1177/20552076231203876</pub-id><pub-id pub-id-type="medline">37780062</pub-id></nlm-citation></ref><ref id="ref97"><label>97</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramos</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Blankers</surname><given-names>M</given-names> </name><name name-style="western"><surname>van Wingen</surname><given-names>G</given-names> </name><name name-style="western"><surname>de Bruijn</surname><given-names>T</given-names> </name><name name-style="western"><surname>Pauws</surname><given-names>SC</given-names> </name><name name-style="western"><surname>Goudriaan</surname><given-names>AE</given-names> </name></person-group><article-title>Predicting success of a digital self-help intervention for alcohol and substance use with machine learning</article-title><source>Front Psychol</source><year>2021</year><volume>12</volume><fpage>734633</fpage><pub-id pub-id-type="doi">10.3389/fpsyg.2021.734633</pub-id><pub-id pub-id-type="medline">34552539</pub-id></nlm-citation></ref><ref id="ref98"><label>98</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>I</given-names> </name><name name-style="western"><surname>Mughal</surname><given-names>F</given-names> </name><name name-style="western"><surname>Bowers</surname><given-names>G</given-names> </name><name name-style="western"><surname>Meiser-Stedman</surname><given-names>R</given-names> </name></person-group><article-title>Dropout from randomised controlled trials of psychological treatments for depression in children and youth: a systematic review and meta-analyses</article-title><source>J Affect Disord</source><year>2021</year><month>02</month><day>15</day><volume>281</volume><fpage>880</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2020.11.039</pub-id><pub-id pub-id-type="medline">33248810</pub-id></nlm-citation></ref><ref id="ref99"><label>99</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olmos</surname><given-names>A</given-names> </name><name name-style="western"><surname>Tirado-Mu&#x00F1;oz</surname><given-names>J</given-names> </name><name name-style="western"><surname>Farr&#x00E9;</surname><given-names>M</given-names> </name><name name-style="western"><surname>Torrens</surname><given-names>M</given-names> </name></person-group><article-title>The efficacy of computerized interventions to reduce cannabis use: a systematic review and meta-analysis</article-title><source>Addict Behav</source><year>2018</year><month>04</month><volume>79</volume><issue>52-60</issue><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2017.11.045</pub-id><pub-id pub-id-type="medline">29248863</pub-id></nlm-citation></ref><ref id="ref100"><label>100</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porath-Waller</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Beasley</surname><given-names>E</given-names> </name><name name-style="western"><surname>Beirness</surname><given-names>DJ</given-names> </name></person-group><article-title>A meta-analytic review of school-based prevention for cannabis use</article-title><source>Health Educ Behav</source><year>2010</year><month>10</month><volume>37</volume><issue>5</issue><fpage>709</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1177/1090198110361315</pub-id><pub-id pub-id-type="medline">20522782</pub-id></nlm-citation></ref><ref id="ref101"><label>101</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kampman</surname><given-names>KM</given-names> </name></person-group><article-title>The treatment of cocaine use disorder</article-title><source>Sci Adv</source><year>2019</year><month>10</month><volume>5</volume><issue>10</issue><fpage>eaax1532</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aax1532</pub-id><pub-id pub-id-type="medline">31663022</pub-id></nlm-citation></ref><ref id="ref102"><label>102</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKay</surname><given-names>JR</given-names> </name></person-group><article-title>Making the hard work of recovery more attractive for those with substance use disorders</article-title><source>Addiction</source><year>2017</year><month>05</month><volume>112</volume><issue>5</issue><fpage>751</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1111/add.13502</pub-id><pub-id pub-id-type="medline">27535787</pub-id></nlm-citation></ref><ref id="ref103"><label>103</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkins</surname><given-names>KE</given-names> </name><name name-style="western"><surname>Ober</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Lamp</surname><given-names>K</given-names> </name><etal/></person-group><article-title>Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial</article-title><source>JAMA Intern Med</source><year>2017</year><month>10</month><day>1</day><volume>177</volume><issue>10</issue><fpage>1480</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2017.3947</pub-id><pub-id pub-id-type="medline">28846769</pub-id></nlm-citation></ref><ref id="ref104"><label>104</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names> </name><name name-style="western"><surname>Koob</surname><given-names>GF</given-names> </name><name name-style="western"><surname>McLellan</surname><given-names>AT</given-names> </name></person-group><article-title>Neurobiologic advances from the brain disease model of addiction</article-title><source>N Engl J Med</source><year>2016</year><month>01</month><day>28</day><volume>374</volume><issue>4</issue><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1511480</pub-id><pub-id pub-id-type="medline">26816013</pub-id></nlm-citation></ref><ref id="ref105"><label>105</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimtz</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Tavares</surname><given-names>AMF</given-names> </name><name name-style="western"><surname>Maftum</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Ferreira</surname><given-names>ACZ</given-names> </name><name name-style="western"><surname>Borba</surname><given-names>LDO</given-names> </name><name name-style="western"><surname>Capistrano</surname><given-names>FC</given-names> </name></person-group><article-title>Impacto do uso de drogas nos relacionamentos familiares de dependentes qu&#x00ED;micos [Article in Spanish]</article-title><source>Cogitare Enferm</source><year>2014</year><access-date>2025-10-06</access-date><volume>19</volume><issue>4</issue><comment><ext-link ext-link-type="uri" xlink:href="http://revistas.ufpr.br/cogitare/issue/view/1843">http://revistas.ufpr.br/cogitare/issue/view/1843</ext-link></comment><pub-id pub-id-type="doi">10.5380/ce.v19i4.35721</pub-id></nlm-citation></ref><ref id="ref106"><label>106</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siqueland</surname><given-names>L</given-names> </name><name name-style="western"><surname>Crits&#x2010;Christoph</surname><given-names>P</given-names> </name><name name-style="western"><surname>Gallop</surname><given-names>R</given-names> </name><etal/></person-group><article-title>Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome</article-title><source>American J Addict</source><year>2002</year><month>01</month><volume>11</volume><issue>1</issue><fpage>24</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1080/10550490252801611</pub-id></nlm-citation></ref><ref id="ref107"><label>107</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>ST</given-names> </name><name name-style="western"><surname>Budney</surname><given-names>AJ</given-names> </name><name name-style="western"><surname>Bickel</surname><given-names>WK</given-names> </name><name name-style="western"><surname>Badger</surname><given-names>GJ</given-names> </name></person-group><article-title>Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence</article-title><source>Am J Drug Alcohol Abuse</source><year>1994</year><volume>20</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.3109/00952999409084056</pub-id><pub-id pub-id-type="medline">8192134</pub-id></nlm-citation></ref><ref id="ref108"><label>108</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelraheem</surname><given-names>O</given-names> </name><name name-style="western"><surname>Salama</surname><given-names>M</given-names> </name><name name-style="western"><surname>Chun</surname><given-names>S</given-names> </name></person-group><article-title>Impact of digital interventions and online health communities in patient activation: systematic review and meta-analysis</article-title><source>Int J Med Inform</source><year>2024</year><month>08</month><volume>188</volume><issue>105481</issue><fpage>105481</fpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2024.105481</pub-id><pub-id pub-id-type="medline">38776718</pub-id></nlm-citation></ref><ref id="ref109"><label>109</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palaz&#x00F3;n-Llecha</surname><given-names>A</given-names> </name><name name-style="western"><surname>Caparr&#x00F3;s</surname><given-names>B</given-names> </name><name name-style="western"><surname>Trujols</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Predictors of cocaine use disorder treatment outcomes: a systematic review</article-title><source>Syst Rev</source><year>2024</year><month>05</month><day>8</day><volume>13</volume><issue>1</issue><fpage>124</fpage><pub-id pub-id-type="doi">10.1186/s13643-024-02550-z</pub-id><pub-id pub-id-type="medline">38720357</pub-id></nlm-citation></ref><ref id="ref110"><label>110</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tofighi</surname><given-names>B</given-names> </name><name name-style="western"><surname>Nicholson</surname><given-names>JM</given-names> </name><name name-style="western"><surname>McNeely</surname><given-names>J</given-names> </name><name name-style="western"><surname>Muench</surname><given-names>F</given-names> </name><name name-style="western"><surname>Lee</surname><given-names>JD</given-names> </name></person-group><article-title>Mobile phone messaging for illicit drug and alcohol dependence: a systematic review of the literature</article-title><source>Drug Alcohol Rev</source><year>2017</year><month>07</month><volume>36</volume><issue>4</issue><fpage>477</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1111/dar.12535</pub-id><pub-id pub-id-type="medline">28474374</pub-id></nlm-citation></ref><ref id="ref111"><label>111</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandez</surname><given-names>E</given-names> </name><name name-style="western"><surname>Salem</surname><given-names>D</given-names> </name><name name-style="western"><surname>Swift</surname><given-names>JK</given-names> </name><name name-style="western"><surname>Ramtahal</surname><given-names>N</given-names> </name></person-group><article-title>Meta-analysis of dropout from cognitive behavioral therapy: magnitude, timing, and moderators</article-title><source>J Consult Clin Psychol</source><year>2015</year><month>12</month><volume>83</volume><issue>6</issue><fpage>1108</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1037/ccp0000044</pub-id><pub-id pub-id-type="medline">26302248</pub-id></nlm-citation></ref><ref id="ref112"><label>112</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>PG</given-names> </name><name name-style="western"><surname>S&#x00F8;nderlund</surname><given-names>AL</given-names> </name></person-group><article-title>Using the internet to research hidden populations of illicit drug users: a review</article-title><source>Addiction</source><year>2010</year><month>09</month><volume>105</volume><issue>9</issue><fpage>1557</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02992.x</pub-id><pub-id pub-id-type="medline">20626378</pub-id></nlm-citation></ref><ref id="ref113"><label>113</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Treweek</surname><given-names>S</given-names> </name><name name-style="western"><surname>Pitkethly</surname><given-names>M</given-names> </name><name name-style="western"><surname>Cook</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Strategies to improve recruitment to randomised trials</article-title><source>Cochrane Database Syst Rev</source><year>2018</year><month>02</month><day>22</day><volume>2</volume><issue>2</issue><fpage>MR000013</fpage><pub-id pub-id-type="doi">10.1002/14651858.MR000013.pub6</pub-id><pub-id pub-id-type="medline">29468635</pub-id></nlm-citation></ref><ref id="ref114"><label>114</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ustinova</surname><given-names>KI</given-names> </name><name name-style="western"><surname>Perkins</surname><given-names>J</given-names> </name><name name-style="western"><surname>Leonard</surname><given-names>WA</given-names> </name><name name-style="western"><surname>Hausbeck</surname><given-names>CJ</given-names> </name></person-group><article-title>Virtual reality game-based therapy for treatment of postural and co-ordination abnormalities secondary to TBI: a pilot study</article-title><source>Brain Inj</source><year>2014</year><volume>28</volume><issue>4</issue><fpage>486</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.3109/02699052.2014.888593</pub-id><pub-id pub-id-type="medline">24702281</pub-id></nlm-citation></ref><ref id="ref115"><label>115</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>MG</given-names> </name><name name-style="western"><surname>Szkodny</surname><given-names>LE</given-names> </name><name name-style="western"><surname>Llera</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Przeworski</surname><given-names>A</given-names> </name></person-group><article-title>A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy?</article-title><source>Clin Psychol Rev</source><year>2011</year><month>02</month><volume>31</volume><issue>1</issue><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2010.09.008</pub-id><pub-id pub-id-type="medline">21130939</pub-id></nlm-citation></ref><ref id="ref116"><label>116</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chekroud</surname><given-names>AM</given-names> </name><name name-style="western"><surname>Bondar</surname><given-names>J</given-names> </name><name name-style="western"><surname>Delgadillo</surname><given-names>J</given-names> </name><etal/></person-group><article-title>The promise of machine learning in predicting treatment outcomes in psychiatry</article-title><source>World Psychiatry</source><year>2021</year><month>06</month><volume>20</volume><issue>2</issue><fpage>154</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1002/wps.20882</pub-id><pub-id pub-id-type="medline">34002503</pub-id></nlm-citation></ref><ref id="ref117"><label>117</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersson</surname><given-names>G</given-names> </name><name name-style="western"><surname>Bergstr&#x00F6;m</surname><given-names>J</given-names> </name><name name-style="western"><surname>Holl&#x00E4;ndare</surname><given-names>F</given-names> </name><name name-style="western"><surname>Carlbring</surname><given-names>P</given-names> </name><name name-style="western"><surname>Kaldo</surname><given-names>V</given-names> </name><name name-style="western"><surname>Ekselius</surname><given-names>L</given-names> </name></person-group><article-title>Internet-based self-help for depression: randomised controlled trial</article-title><source>Br J Psychiatry</source><year>2005</year><month>11</month><volume>187</volume><issue>5</issue><fpage>456</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1192/bjp.187.5.456</pub-id><pub-id pub-id-type="medline">16260822</pub-id></nlm-citation></ref><ref id="ref118"><label>118</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>D</given-names> </name><name name-style="western"><surname>Richardson</surname><given-names>T</given-names> </name></person-group><article-title>Computer-based psychological treatments for depression: a systematic review and meta-analysis</article-title><source>Clin Psychol Rev</source><year>2012</year><month>06</month><volume>32</volume><issue>4</issue><fpage>329</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2012.02.004</pub-id><pub-id pub-id-type="medline">22466510</pub-id></nlm-citation></ref><ref id="ref119"><label>119</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merry</surname><given-names>SN</given-names> </name><name name-style="western"><surname>Stasiak</surname><given-names>K</given-names> </name><name name-style="western"><surname>Shepherd</surname><given-names>M</given-names> </name><name name-style="western"><surname>Frampton</surname><given-names>C</given-names> </name><name name-style="western"><surname>Fleming</surname><given-names>T</given-names> </name><name name-style="western"><surname>Lucassen</surname><given-names>MFG</given-names> </name></person-group><article-title>The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial</article-title><source>BMJ</source><year>2012</year><month>04</month><day>18</day><volume>344</volume><issue>apr18 3</issue><fpage>e2598</fpage><pub-id pub-id-type="doi">10.1136/bmj.e2598</pub-id><pub-id pub-id-type="medline">22517917</pub-id></nlm-citation></ref><ref id="ref120"><label>120</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warmerdam</surname><given-names>L</given-names> </name><name name-style="western"><surname>van Straten</surname><given-names>A</given-names> </name><name name-style="western"><surname>Twisk</surname><given-names>J</given-names> </name><name name-style="western"><surname>Riper</surname><given-names>H</given-names> </name><name name-style="western"><surname>Cuijpers</surname><given-names>P</given-names> </name></person-group><article-title>Internet-based treatment for adults with depressive symptoms: randomized controlled trial</article-title><source>J Med Internet Res</source><year>2008</year><month>11</month><day>20</day><volume>10</volume><issue>4</issue><fpage>e44</fpage><pub-id pub-id-type="doi">10.2196/jmir.1094</pub-id><pub-id pub-id-type="medline">19033149</pub-id></nlm-citation></ref><ref id="ref121"><label>121</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>TM</given-names> </name><name name-style="western"><surname>de Beurs</surname><given-names>D</given-names> </name><name name-style="western"><surname>Khazaal</surname><given-names>Y</given-names> </name><etal/></person-group><article-title>Maximizing the impact of e-therapy and serious gaming: time for a paradigm shift</article-title><source>Front Psychiatr</source><year>2016</year><volume>7</volume><issue>65</issue><fpage>65</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2016.00065</pub-id><pub-id pub-id-type="medline">27148094</pub-id></nlm-citation></ref><ref id="ref122"><label>122</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girard</surname><given-names>B</given-names> </name><name name-style="western"><surname>Turcotte</surname><given-names>V</given-names> </name><name name-style="western"><surname>Bouchard</surname><given-names>S</given-names> </name><name name-style="western"><surname>Girard</surname><given-names>B</given-names> </name></person-group><article-title>Crushing virtual cigarettes reduces tobacco addiction and treatment discontinuation</article-title><source>Cyberpsychol Behav</source><year>2009</year><month>10</month><volume>12</volume><issue>5</issue><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1089/cpb.2009.0118</pub-id><pub-id pub-id-type="medline">19817561</pub-id></nlm-citation></ref><ref id="ref123"><label>123</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ackerman</surname><given-names>SJ</given-names> </name><name name-style="western"><surname>Hilsenroth</surname><given-names>MJ</given-names> </name><name name-style="western"><surname>Baity</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Blagys</surname><given-names>MD</given-names> </name></person-group><article-title>Interaction of therapeutic process and alliance during psychological assessment</article-title><source>J Pers Assess</source><year>2000</year><month>08</month><volume>75</volume><issue>1</issue><fpage>82</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1207/S15327752JPA7501_7</pub-id><pub-id pub-id-type="medline">10941703</pub-id></nlm-citation></ref><ref id="ref124"><label>124</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anguera</surname><given-names>JA</given-names> </name><name name-style="western"><surname>Boccanfuso</surname><given-names>J</given-names> </name><name name-style="western"><surname>Rintoul</surname><given-names>JL</given-names> </name><etal/></person-group><article-title>Video game training enhances cognitive control in older adults</article-title><source>Nature New Biol</source><year>2013</year><month>09</month><day>5</day><volume>501</volume><issue>7465</issue><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/nature12486</pub-id><pub-id pub-id-type="medline">24005416</pub-id></nlm-citation></ref><ref id="ref125"><label>125</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prosperini</surname><given-names>L</given-names> </name><name name-style="western"><surname>Fanelli</surname><given-names>F</given-names> </name><name name-style="western"><surname>Petsas</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Multiple sclerosis: changes in microarchitecture of white matter tracts after training with a video game balance board</article-title><source>Radiology</source><year>2014</year><month>11</month><volume>273</volume><issue>2</issue><fpage>529</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1148/radiol.14140168</pub-id><pub-id pub-id-type="medline">25158046</pub-id></nlm-citation></ref><ref id="ref126"><label>126</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staiano</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Abraham</surname><given-names>AA</given-names> </name><name name-style="western"><surname>Calvert</surname><given-names>SL</given-names> </name></person-group><article-title>Adolescent exergame play for weight loss and psychosocial improvement: a controlled physical activity intervention</article-title><source>Obesity (Silver Spring)</source><year>2013</year><month>03</month><volume>21</volume><issue>3</issue><fpage>598</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1002/oby.20282</pub-id><pub-id pub-id-type="medline">23592669</pub-id></nlm-citation></ref><ref id="ref127"><label>127</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fish</surname><given-names>MT</given-names> </name><name name-style="western"><surname>Russoniello</surname><given-names>CV</given-names> </name><name name-style="western"><surname>O&#x2019;Brien</surname><given-names>K</given-names> </name></person-group><article-title>The efficacy of prescribed casual videogame play in reducing symptoms of anxiety: a randomized controlled study</article-title><source>Games Health J</source><year>2014</year><month>10</month><volume>3</volume><issue>5</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1089/g4h.2013.0092</pub-id><pub-id pub-id-type="medline">26192483</pub-id></nlm-citation></ref><ref id="ref128"><label>128</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botella</surname><given-names>C</given-names> </name><name name-style="western"><surname>Breton-L&#x00F3;pez</surname><given-names>J</given-names> </name><name name-style="western"><surname>Quero</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Treating cockroach phobia using a serious game on a mobile phone and augmented reality exposure: a single case study</article-title><source>Comput Human Behav</source><year>2011</year><month>01</month><volume>27</volume><issue>1</issue><fpage>217</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.chb.2010.07.043</pub-id></nlm-citation></ref><ref id="ref129"><label>129</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsch</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Bickel</surname><given-names>WK</given-names> </name></person-group><article-title>Efficacy of computer-based HIV/AIDS education for injection drug users</article-title><source>Am J Health Behav</source><year>2004</year><volume>28</volume><issue>4</issue><fpage>316</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.5993/ajhb.28.4.3</pub-id><pub-id pub-id-type="medline">15228968</pub-id></nlm-citation></ref><ref id="ref130"><label>130</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sander</surname><given-names>LB</given-names> </name><name name-style="western"><surname>Beisemann</surname><given-names>M</given-names> </name><name name-style="western"><surname>Doebler</surname><given-names>P</given-names> </name><etal/></person-group><article-title>The effects of internet-based cognitive behavioral therapy for suicidal ideation or behaviors on depression, anxiety, and hopelessness in individuals with suicidal ideation: systematic review and meta-analysis of individual participant data</article-title><source>J Med Internet Res</source><year>2023</year><month>06</month><day>26</day><volume>25</volume><fpage>e46771</fpage><pub-id pub-id-type="doi">10.2196/46771</pub-id><pub-id pub-id-type="medline">37358893</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Search strategy.</p><media xlink:href="jmir_v27i1e77853_app1.doc" xlink:title="DOC File, 47 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Risk of bias.</p><media xlink:href="jmir_v27i1e77853_app2.docx" xlink:title="DOCX File, 301 KB"/></supplementary-material><supplementary-material id="app3"><label>Checklist 1</label><p>PRISMA 2020 checklist.</p><media xlink:href="jmir_v27i1e77853_app3.doc" xlink:title="DOC File, 68 KB"/></supplementary-material></app-group></back></article>